<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2026.1735570</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>An integrative ultrastructural and transcriptomic analysis of host&#x2013;pathogen interactions with human brain microvascular endothelial cells during cryptococcal infection: a preliminary study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Krishnan</surname><given-names>Priya</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Udupi</surname><given-names>Gautham Arunachal</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Santhoshkumar</surname><given-names>Rashmi</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2700521/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
</contrib>
<contrib contrib-type="author">
<name><surname>M. V.</surname><given-names>Manjunatha.</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref> 
<uri xlink:href="https://loop.frontiersin.org/people/1355834/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
</contrib>
<contrib contrib-type="author">
<name><surname>H. B.</surname><given-names>Veena Kumari</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3258783/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Netravathi</surname></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2414391/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>S.</surname><given-names>Nagarathna</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3133677/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Dept of Neuromicrobiology, National Institute of Mental Health and Neuro Sciences, Institute of National Importance</institution>, <city>Bengaluru</city>, <country country="in">India</country></aff>
<aff id="aff2"><label>2</label><institution>Dept of Human Genetics, National Institute of Mental Health and Neuro Sciences, Institute of National Importance</institution>, <city>Bengaluru</city>, <country country="in">India</country></aff>
<aff id="aff3"><label>3</label><institution>Dept of Neuropathology, National Institute of Mental Health and Neuro Sciences, Institute of National Importance</institution>, <city>Bengaluru</city>, <country country="in">India</country></aff>
<aff id="aff4"><label>4</label><institution>Dept of Neurovirology, National Institute of Mental Health and Neuro Sciences, Institute of National Importance</institution>, <city>Bengaluru</city>, <country country="in">India</country></aff>
<aff id="aff5"><label>5</label><institution>Dept of Neurology, National Institute of Mental Health and Neuro Sciences, Institute of National Importance</institution>, <city>Bengaluru</city>, <country country="in">India</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Nagarathna S., <email xlink:href="mailto:nagarathnachandrashekar@gmail.com">nagarathnachandrashekar@gmail.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-09">
<day>09</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>16</volume>
<elocation-id>1735570</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Krishnan, Udupi, Santhoshkumar, M. V., H. B., Netravathi and S.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Krishnan, Udupi, Santhoshkumar, M. V., H. B., Netravathi and S.</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-09">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>In humans, <italic>Cryptococcus neoformans</italic> and <italic>Cryptococcus gattii</italic> species complexes are the leading cause of fungal meningitis globally. To establish CNS infection, <italic>Cryptococcus</italic> must breach the BBB, primarily comprised of specialized brain microvascular endothelial cells (BMECs), which is the prerequisite for cryptococci to invade the brain. Despite its clinical impact, the mechanisms underlying host&#x2013;pathogen interaction at the BBB particularly involving environmental isolates remain under-characterized.</p>
</sec>
<sec>
<title>Objective</title>
<p>This study aimed to investigate the cyto-morphological and transcriptomic responses of HBMECs to infection by clinical and environmental <italic>Cryptococcus</italic> isolates using a dual approach&#x2014;ultrastructural electron microscopy and high-throughput dual RNA-Seq.</p>
</sec>
<sec>
<title>Methods</title>
<p>HBMECs were infected <italic>in vitro</italic> with molecularly typed clinical and environmental isolates of <italic>C. neoformans</italic> and <italic>C. gattii</italic> at two infection time points (4 hpi and 18 hpi). Transmission electron microscopy was used to visualize host cell ultrastructural alterations, while dual RNA-Seq was performed to assess differential gene expression in both host and pathogen.</p>
</sec>
<sec>
<title>Results</title>
<p>TEM revealed extensive ultrastructural changes in infected HBMECs, including membrane ruffling, increased microvilli, mitochondrial alterations, ER dilation, Golgi fragmentation, nuclear deformation, and autophagosome formation. Transcriptomic profiling demonstrated functional enrichment of several critical cryptococcal virulence-associated genes linked to immune evasion and stress adaptation including various immune signaling pathways elicited by the HBMECs as a counter measure to the cryptococcal invasion.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Clinical and environmental <italic>Cryptococcus</italic> isolates exhibit comparable invasive potential and elicit similar host endothelial responses with consistent effects observed across all isolates and time points. This integrative study combining ultrastructural and transcriptomic analyses highlights conserved host-pathogen interactions at the BBB, identifies potential molecular targets for antifungal therapy and underscores the pathogenic relevance of environmental reservoirs in cryptococcal meningitis. cryptococcal meningitis, blood-brain barrier, invasion, transmission electron microscopy, Dual RNASeq, differential gene expression, host-pathogen interaction, HBMECs, ultrastructural alterations.</p>
</sec>
</abstract>
<kwd-group>
<kwd>blood-brain barrier</kwd>
<kwd>cryptococcal meningitis</kwd>
<kwd>differential gene expression</kwd>
<kwd>dual RNAseq</kwd>
<kwd>HBMECs</kwd>
<kwd>host-pathogen interaction</kwd>
<kwd>invasion</kwd>
<kwd>transmission electron microscopy</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was partly funded by the Department of Science and Technology&#x2013;Science and Engineering Research Board (DST&#x2013;SERB), Government of India, with the remaining expenses supported by the authors.</funding-statement>
</funding-group>
<counts>
<fig-count count="8"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="80"/>
<page-count count="21"/>
<word-count count="10862"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Fungal Pathogenesis</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Cryptococcosis, the disease caused by the environmental fungi <italic>Cryptococcus neoformans</italic> and <italic>Cryptococcus gattii</italic>, typically manifests as severe pulmonary infection and can progress to cryptococcal meningitis, a serious condition affecting the central nervous system. These pathogens primarily affect individuals with compromised immune systems, but an increasing number of cases have also been reported in immunocompetent hosts contributing significantly to global morbidity and mortality (<xref ref-type="bibr" rid="B48">Maziarz and Perfect, 2015</xref>; <xref ref-type="bibr" rid="B10">Diniz-Lima et&#xa0;al., 2022</xref>). The infection is primarily acquired by the inhalation of desiccated airborne yeast cells which establishes itself within the alveoli and may remain dormant for years and later on spread to other organs more often the CNS owing to its neurotropism (<xref ref-type="bibr" rid="B51">Negroni and Arechavala, 2015</xref>; <xref ref-type="bibr" rid="B71">Taylor-Smith, 2017</xref>). Invasion of <italic>Cryptococcus</italic> into the CNS necessitates crossing the Blood&#x2013;brain barrier (BBB) (<xref ref-type="bibr" rid="B5">Casadevall et&#xa0;al., 2018</xref>) which serves as a critical interface between the systemic circulation and the CNS regulating the passage of molecules and pathogens into the brain (<xref ref-type="bibr" rid="B35">Kadry et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B80">Zhou et&#xa0;al., 2024</xref>).</p>
<p>In their natural habitat, <italic>C.neoformans</italic> species complex (serotypes A and D) are most frequently isolated from soil contaminated with pigeon guano and other avian habitats and has also been recovered from desiccated accumulations of bird droppings. Conversely, <italic>C.gattii</italic> species complex (serotypes B and C) has been associated with dried and decayed materials of <italic>Eucalyptus camaldulensis</italic> and pine trees (<xref ref-type="bibr" rid="B10">Diniz-Lima et&#xa0;al., 2022</xref>). In this study, we isolated <italic>C.neoformans</italic> and <italic>C.gattii</italic> from these ecological sources. These environmental isolates lack prior human host exposure, unlike clinical <italic>Cryptococcus</italic> isolates that have encountered the challenging conditions within the human host. A key event in cryptococcal invasion involves the interaction of the fungal pathogen with the brain endothelial cells and adapts itself to survive within the nutrient-deprived environment of the brain. During the cryptococcal invasion into BBB, significantly marked morphological changes was observed in the endothelial cells indicating that <italic>Cryptococcus</italic> induced host cell actin cytoskeletal reorganization (<xref ref-type="bibr" rid="B21">Gal&#xe1;n and Zhou, 2000</xref>; <xref ref-type="bibr" rid="B7">Chen et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B11">Eug&#xe8;ne et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B6">Chen et&#xa0;al., 2003</xref>). May et&#xa0;al., in their comprehensive review, described numerous discoveries that highlight the intricacies of interactions between the host and <italic>Cryptococcus</italic> influencing the disease severity (<xref ref-type="bibr" rid="B47">May et&#xa0;al., 2016</xref>). In addition, previous experimental studies have demonstrated unique expression profiles among different mutants or reference cryptococcal strains under various conditions (<xref ref-type="bibr" rid="B67">Steen et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B14">Florio et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B69">Tavares et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B79">Yu et&#xa0;al., 2021</xref>). A study conducted by Yu et&#xa0;al. comparing the transcriptomic variations of clinical and environmental isolates of <italic>C.neoformans</italic>, highlighted on genes with lineage-specific expression providing insights into genes important for <italic>in vitro</italic> and <italic>in vivo</italic> growth stages (<xref ref-type="bibr" rid="B78">Yu et&#xa0;al., 2020</xref>).</p>
<p>However, while considerable research has explored the behavior of laboratory or clinical isolates of <italic>Cryptococcus in vitro</italic> and <italic>in vivo</italic>, relatively little is known about the virulence potential of environmental isolates, particularly in terms of their ability to invade brain endothelial cells and the resulting host response. In this context, our study investigates whether environmental isolates of <italic>C.neoformans</italic> and <italic>C. gattii</italic> possess invasive capabilities comparable to clinical isolates in breaching the BBB endothelium and characterize the associated ultrastructural and transcriptional responses of HBMECs during fungal invasion. To achieve this, we employed an integrative approach combining high-resolution transmission electron microscopy (TEM) with dual RNA sequencing (RNA-Seq).</p>
<p>This study represents a preliminary yet comprehensive effort to provide foundational insights into early endothelial responses to infection by clinical and environmental <italic>Cryptococcus</italic> isolates, enhancing our understanding of host&#x2013;pathogen interactions at the BBB using an <italic>in vitro</italic> co-culture system. TEM was employed to examine host cellular architecture, revealing changes in membrane dynamics, organelle morphology, and structural adaptations induced by fungal invasion. Complementing this, high-throughput dual RNA sequencing enabled simultaneous profiling of host and pathogen gene expression, uncovering differential expression of virulence-associated fungal genes and activation of diverse immune signaling pathways in HBMECs. This integrative approach provides critical insights into the cellular and molecular mechanisms underlying cryptococcal invasion of the BBB.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Clinical and environmental isolates of <italic>Cryptococcus</italic> species complex</title>
<p>The study was conducted in the Department of Neuromicrobiology at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru. Only laboratory-confirmed cases of cryptococcal meningitis established by cryptococcal antigen detection and fungal culture were included. The experimental work was conducted using <italic>Cryptococcus</italic> isolates recovered from the diagnostic CSF samples obtained from patients of all age groups. The isolates were further confirmed using MALDI -TOF MS or VITEK 2 compact system. The study was conducted in compliance with approvals obtained from the Institutional Ethics Committee and Institutional Biosafety Committee.</p>
<p>The environmental isolates of <italic>Cryptococcus</italic> were recovered from dried pigeon droppings and decayed material from Eucalyptus trees (flower, bark, leaves and soil contaminated with bird guano) as per the protocol outlined in the previous studies (<xref ref-type="bibr" rid="B56">Pham et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B52">Nweze et&#xa0;al., 2015</xref>) subsequently identified by standard conventional and automated methods.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title><italic>In vitro</italic> monolayer cell culture of HBMECs</title>
<p>HBMECs were a generous and kind contribution by late Dr. Kwang Sik Kim, Professor of Pediatrics, Johns Hopkins University, Baltimore, USA and Dr. Anirban Banerjee, Professor, IIT, Mumbai towards the proposed objectives. The anchorage dependent HBMECs were seeded onto treated cell culture petri plates supplemented with growth media RPMI 1640 (Gibco) containing 10% FBS (Gibco), 10% Nuserum (Corning), 1% Minimum Essential media (Gibco), 0.5% Pen-Strep (Gibco) and incubated at 37<sup>0</sup> C with 5%CO<sub>2</sub> maintained (<xref ref-type="bibr" rid="B33">Jong et&#xa0;al., 2008</xref>). The plates were periodically monitored to ensure healthy growth and confluence with particular attention towards depletion of nutritional resources.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Infection of HBMECs with <italic>Cryptococcus</italic></title>
<p>The isolates were selected (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>) for infecting HBMECs based on their molecular types, determined using the PCR fingerprinting technique with a synthetic oligonucleotide, (GTG)5 primer, following the protocol outlined by Tay et&#xa0;al (<xref ref-type="bibr" rid="B70">Tay et&#xa0;al., 2006</xref>). The molecular type of each isolate was assigned by comparison with the control strains of <italic>Cryptococcus</italic> corresponding to VNI-VNIV, VNB and VGI-VGIV. As the HBMEC monolayers reached approximately 70&#x2013;80% confluence, cells were infected with <italic>Cryptococcus neoformans/gattii</italic> isolates derived from both clinical and environmental sources. Yeast cells were grown to the early logarithmic phase in YEPD broth (HiMedia), harvested, washed, and resuspended in endothelial growth medium. The fungal inoculum was quantified using a hemocytometer and adjusted to achieve a final concentration of approximately 1 &#xd7; 10<sup>6</sup> CFU/mL corresponding to a multiplicity of infection (MOI) of ~10 as described previously (<xref ref-type="bibr" rid="B40">Lahiri et&#xa0;al., 2019</xref>). Infected cultures were incubated at 37&#xb0;C in a humidified atmosphere containing 5% CO<sub>2</sub>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>List of clinical and environmental isolates of <italic>Cryptococcus</italic> selected based on their molecular types to infect HBMECs.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Sl No.</th>
<th valign="middle" align="center">Isolates</th>
<th valign="middle" align="center">Isolate ID</th>
<th valign="middle" align="center">Isolate Name</th>
<th valign="middle" align="center">Molecular type</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">1.&#x2003;</td>
<td valign="middle" rowspan="4" align="center">Clinical isolates</td>
<td valign="middle" align="left">CL_Cneo_35</td>
<td valign="middle" align="left"><italic>C. neoformans</italic></td>
<td valign="middle" align="center">VN II</td>
</tr>
<tr>
<td valign="middle" align="left">2.&#x2003;</td>
<td valign="middle" align="left">CL_Cneo_52</td>
<td valign="middle" align="left"><italic>C. neoformans</italic></td>
<td valign="middle" align="center">VN I</td>
</tr>
<tr>
<td valign="middle" align="left">3.&#x2003;</td>
<td valign="middle" align="left">CL_Cgattii_76</td>
<td valign="middle" align="left"><italic>C. gattii</italic></td>
<td valign="middle" align="center">VG IV</td>
</tr>
<tr>
<td valign="middle" align="left">4.&#x2003;</td>
<td valign="middle" align="left">CL_Cgattii_77</td>
<td valign="middle" align="left"><italic>C. gattii</italic></td>
<td valign="middle" align="center">VG IV</td>
</tr>
<tr>
<td valign="middle" align="left">5.&#x2003;</td>
<td valign="middle" rowspan="4" align="center">Environmental isolates</td>
<td valign="middle" align="left">EN_Cneo_12</td>
<td valign="middle" align="left"><italic>C. neoformans</italic></td>
<td valign="middle" align="center">VN I</td>
</tr>
<tr>
<td valign="middle" align="left">6.&#x2003;</td>
<td valign="middle" align="left">EN_Cneo_24</td>
<td valign="middle" align="left"><italic>C. neoformans</italic></td>
<td valign="middle" align="center">VN II</td>
</tr>
<tr>
<td valign="middle" align="left">7.&#x2003;</td>
<td valign="middle" align="left">EN_Cgattii_26</td>
<td valign="middle" align="left"><italic>C. gattii</italic></td>
<td valign="middle" align="center">VG IV</td>
</tr>
<tr>
<td valign="middle" align="left">8.&#x2003;</td>
<td valign="middle" align="left">EN_Cgattii_28</td>
<td valign="middle" align="left"><italic>C. gattii</italic></td>
<td valign="middle" align="center">VG IV</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The study included a total of eight <italic>Cryptococcus</italic> isolates, comprising two isolates each of <italic>C.neoformans</italic> and <italic>C. gattii</italic> from clinical sources and two isolates each of <italic>C. neoformans</italic> and <italic>C. gattii</italic> from environmental sources (n = 8; <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>). At the end of 4<sup>th</sup> and 18<sup>th</sup> hour of incubation the cells were gently washed with PBS to remove unbound and extracellular yeast. Following incubation cells were harvested for downstream analyses. Invasion was confirmed by CFU enumeration on Sabouraud dextrose agar following Triton X-100 lysis. Infected cultures were analyzed and compared to uninfected controls at two distinct time points to assess morphological alterations and differential gene expression in both the host and pathogen.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Cyto-morphological study by transmission electron microscopy</title>
<p>Transmission electron microscopy was performed in duplicate independent experiments on HBMECs infected with <italic>Cryptococcus neoformans/gattii</italic> isolates derived from both clinical and environmental sources (n = 8 isolates; <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>) at 4 and 18 hpi, along with uninfected controls. The HBMECs at the end of 4<sup>th</sup> and 18<sup>th</sup> hpi and the uninfected controls were primarily fixed in 4% paraformaldehyde and 2.5% glutaraldehyde. The cells were secondarily fixed in 1% Osmium tetroxide and dehydrated with graded series of distilled ethanol (70%, 80%, 90%, 95% &amp; 100%) for 1hour each at 4<sup>0</sup>C. Clearing of the cells in propylene oxide was performed twice. Infiltration with propylene oxide: Araldite resin (1:1 ratio) for overnight followed by increasing proportion of araldite (1:2 &amp; 1:3 ratios) for one hour respectively. Finally, the cell pellets were embedded in pure resin and polymerized at 60<sup>0</sup>C.</p>
<p>Using ultramicrotome (Leica UC7, Germany) ultrathin sections were collected on copper grids and stained using Leica EM AC20 automatic contrasting system (Leica, Germany). Saturated methanolic uranyl acetate (TAAB, UK) and 3% aqueous lead citrate (Ultrostain 2) were used for staining. For each experimental condition, 4&#x2013;5 ultrathin-section grids were prepared and multiple microscopic fields were examined at varying magnifications to capture representative ultrastructural features. Imaging was performed using the transmission electron microscope JEM 1400-Plus, JEOL (Tokyo, Japan).</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Dual RNA seq and bioinformatics</title>
<sec id="s2_5_1">
<label>2.5.1</label>
<title>RNA extraction and sequencing</title>
<p>RNA was extracted from 16 co-cultures and 5 baseline controls using the Qiagen RNeasy Mini Kit. RNA quality and concentration were assessed using Nanodrop spectrophotometry (<italic>A</italic><sub>260</sub>/<italic>A</italic><sub>280</sub> purity ratio of ~2.0), agarose gel electrophoresis, and Agilent Bioanalyzer to determine RNA integrity (RIN score). Libraries were prepared from high-quality RNA using the TruSeq Stranded mRNA kit (Illumina), with fluorometric quantification using Invitrogen Qubit Fluorometer. A total of 42 cDNA libraries (16 co-cultures and 5 baseline controls in duplicate) were constructed and the library quality was validated using the Bioanalyzer DNA 1000 chip. Libraries were normalized, pooled, denatured, and sequenced in replicates on the Illumina NextSeq 550 platform using high-throughput massively parallel sequencing technology.</p>
</sec>
<sec id="s2_5_2">
<label>2.5.2</label>
<title>Bioinformatics pipelines</title>
<p>The initial raw sequences obtained from the sequencing facility were presented as FastQ files in a single end configuration with 76 base pair reads. A subset of FASTQ files were submitted to the BLAST database to check for the possible contamination and confirm that the hits were in agreement with the expected organism. The quality of the reads was assessed using FASTQC and Cutadapt to remove the poor quality reads and adapter/ primer sequences. The dual RNASeq data were further filtered based on the read length and quality scores. The&#xa0;high quality reads with Phred score &gt;30 were considered and mapped to the human reference genome and the unmapped reads were aligned to the second reference genome of <italic>Cryptococcus</italic> species in the RNA-Seq Alignment workflow using STAR aligner. <italic>Cryptococcus neoformans / gattii</italic> species complex reference genome was generated using the RNA custom genome builder app version 2.0.2 by obtaining the FASTA and GTF genome annotated file formats from Fungi Ensembl database. The aligned read counts were then quantified using RNA differential expression workflow that enables the detection of differentially expressed genes by employing DESeq2 pipeline. The statistical package R was used for visualizing the gene expression patterns and to identify the differentially expressed genes in both the pathogen (yeast) and the host (HBMECs) and the results were obtained as graphs and tables. Further the web based tool DAVID was used for the functional enrichment analysis of DEGs extracted by Gene Ontology and the significantly altered pathways associated with the DEGs were determined using KEGG pathway maps for the host. We performed the functional categorization of differentially expressed genes of fungal pathogen by using Gene Ontology employing FungiDB and FungiFun 2.2.8 BETA web based tools (<xref ref-type="bibr" rid="B58">Priebe et&#xa0;al., 2015</xref>).</p>
</sec>
<sec id="s2_5_3">
<label>2.5.3</label>
<title>qPCR validation</title>
<p>A total of nine genes, including both HBMECs (FOS, FOSB, DDIT4, VEGFA, TRIB3, FOS, FOSB) and <italic>Cryptococcus</italic> (CGB_A4480W, CGB_A4770W) transcripts, were selected for validation using quantitative real-time PCR (qPCR). Total RNA used for sequencing and qPCR was DNase-treated and reverse transcribed to cDNA using the Takara cDNA conversion kit following the manufacturer&#x2019;s instructions. qPCR reactions were performed in duplicate with 20 ng/&#x3bc;L cDNA in a 25 &#x3bc;L reaction using Takara SYBR Green master mix (Agilent Technologies, USA) on an Agilent AriaMx Real-Time PCR system. The cycling conditions included initial denaturation at 95&#xb0;C for 30 sec, followed by 40 cycles of 95&#xb0;C for 5 sec and 60&#xb0;C for 34 sec. The dissociation curve analysis confirmed primer specificity. Relative expression levels were calculated using the 2^-&#x394;&#x394;Ct method. &#x3b2;-actin for HBMECs and CGB_Act for <italic>Cryptococcus</italic> served as reference genes for normalizing the qPCR experiment. Pearson&#x2019;s correlation test was used to assess concordance between RNA-Seq and qPCR data.</p>
</sec>
<sec id="s2_5_4">
<label>2.5.4</label>
<title>Comparison categories</title>
<p>To mark the expression differences among various entities the interacting co-cultures were compared to the baseline controls at two different time points. Therefore, the following groupings were assigned for the clearer perception of the comparisons made (<xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Challenged HBMECs co-culture categories.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Treated Co-culture categories</th>
<th valign="middle" align="center">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">CLCneo_T4</td>
<td valign="middle" align="left">HBMECs infected with clinical isolate of <italic>C.neoformans</italic> retrieved at 4<sup>th</sup> hpi</td>
</tr>
<tr>
<td valign="middle" align="left">CLCneo_T18</td>
<td valign="middle" align="left">HBMECs infected with clinical isolate of <italic>C.neoformans</italic> retrieved at 18<sup>th</sup> hpi</td>
</tr>
<tr>
<td valign="middle" align="left">CLCgattii_T4</td>
<td valign="middle" align="left">HBMECs infected with clinical isolate of <italic>C.gattii</italic> retrieved at 4<sup>th</sup> hpi</td>
</tr>
<tr>
<td valign="middle" align="left">CLCgattii_T18</td>
<td valign="middle" align="left">HBMECs infected with clinical isolate of <italic>C.gattii</italic> retrieved at 18<sup>th</sup> hpi</td>
</tr>
<tr>
<td valign="middle" align="left">ENCneo_T4</td>
<td valign="middle" align="left">HBMECs infected with environmental isolate of <italic>C.neoformans</italic> retrieved at 4<sup>th</sup> hpi</td>
</tr>
<tr>
<td valign="middle" align="left">ENCneo_T18</td>
<td valign="middle" align="left">HBMECs infected with environmental isolate of <italic>C.neoformans</italic> retrieved at 18<sup>th</sup> hpi</td>
</tr>
<tr>
<td valign="middle" align="left">ENCgattii_T4</td>
<td valign="middle" align="left">HBMECs infected with environmental isolate of <italic>C.gattii</italic> retrieved at 4<sup>th</sup> hpi</td>
</tr>
<tr>
<td valign="middle" align="left">ENCgattii_T18</td>
<td valign="middle" align="left">HBMECs infected with environmental isolate of <italic>C.gattii</italic> retrieved at 18<sup>th</sup> hpi</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Cyto-morphological changes of challenged HBMECs</title>
<p>In their uninfected state, HBMEC displayed typical elongated endothelial morphology with relatively smooth, flat cell membrane and a spherical to oval shaped nucleus. Intracellular organelles such as mitochondria, Golgi complex, ER and nucleus were identifiable. Upon exposure to <italic>Cryptococcus</italic>, there were substantial degenerative changes observed in the regular morphology of HBMECs. The electron micrographs, <xref ref-type="fig" rid="f1"><bold>Figures&#xa0;1B, C</bold></xref> depicts the presence of <italic>Cryptococcus</italic> yeast cells that have invaded the microvascular endothelial cells. <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1D</bold></xref> offers a view of the active involvement of the endothelial cell membrane in engulfing the yeast cell exhibiting striking membrane invagination and the extension of microvilli projections to encapsulate the invading <italic>Cryptococcus</italic>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The electron micrographs shown are representative images of HBMECs obtained from duplicate independent experiments performed by infecting with <italic>Cryptococcus neoformans/ gattii</italic> species complex isolates derived from both clinical and environmental sources. For each experimental condition, 4&#x2013;5 ultrathin-section grids were examined, and multiple microscopic fields (~10&#x2013;12 fields) were analyzed at the indicated magnifications. <bold>(A)</bold> uninfected HBMEC (x1500); <bold>(B)</bold> endothelial cell with invaded <italic>Cryptococcus</italic> (x1200); <bold>(C)</bold> endothelial cell containing two <italic>Cryptococcus</italic> within (x1500); <bold>(D)</bold> endothelial cell exhibiting membrane invagination during the engulfment of <italic>Cryptococcus</italic> (x4000); <bold>(E, F)</bold> HBMECs showing membrane ruffling and extensive microvilli formation (x800, x1500); <bold>(G&#x2013; I)</bold> HBMECs undergoing autophagy showing the presence of autophagic vacuoles or autophagosomes (x8000, x5000, x1200).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1735570-g001.tif">
<alt-text content-type="machine-generated">Electron micrographs depicting cellular structures with varying details. Image A shows intricate cell architecture with a prominent nucleus. Image B highlights a white circled structure inside a dense cellular area. Image C displays two white circular features with a rough surrounding area. Image D focuses on a close-up of a large central white area. Images E and F present network-like structures forming complex patterns. Images G and H contain smaller circular elements within dense regions. Image I shows a cross-section of a cell with prominent internal features. Each image is annotated with arrows and scale bars.</alt-text>
</graphic></fig>
<p>The sub microscopic preparations of infected HBMECs revealed notable membrane ruffling and extensive formation of microvilli (<xref ref-type="fig" rid="f1"><bold>Figures&#xa0;1E, F</bold></xref>). In contrast, the uninfected HBMECs showed the minimal presence of microvilli (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>) as these structures are part of their physiological characteristics that aid in increasing the cell surface area. Interestingly, we noticed the presence of irregular and large protrusions, folds or undulations on the cell membrane of infected HBMECs referred to as membrane ruffles. Remarkably, we observed HBMECs exhibiting autophagy in response to cryptococcal infection as an important cellular defense mechanism. Membrane bound vesicles known as autophagic vacuoles or autophagosomes were formed within the endothelial cell that probably involves the degradation and recycling of cellular components, such as damaged/ vacuolated organelles and intracellular pathogens (<xref ref-type="fig" rid="f1"><bold>Figures&#xa0;1G, H, I</bold></xref>).</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Ultrafine subcellular structural alterations</title>
<sec id="s3_2_1">
<label>3.2.1</label>
<title>Mitochondria</title>
<p>In their uninfected state, HBMECs exhibited typical mitochondrial morphology characterized by intact membranes and a well-defined cristae pattern (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2A</bold></xref>). However, upon infection with <italic>Cryptococcus</italic>, there was a profound and degenerative impact on the mitochondrial morphology. At 4<sup>th</sup> hour time point post infection, mitochondria displayed partial alterations with slight dilated appearance and less distinguishable cristae pattern (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>). In contrast, at 18<sup>th</sup> hour infection time point, there was significant loss of mitochondrial integrity accompanied by aberrant architectural remodeling, appearing invariably swollen with distorted morphology, the cristae pattern was completely disrupted, membranes seemed irregular and detached. Furthermore, the mitochondria appeared vacuolated and there was decrease in matrix density, all indicative of severe mitochondrial dysfunction (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2C</bold></xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The electron micrographs shown are representative images of HBMECs obtained from duplicate independent experiments performed by infecting with <italic>Cryptococcus neoformans/gattii</italic> species complex isolates derived from both clinical and environmental sources showing subcellular changes at 4th and 18th hour post infection. For each experimental condition, 4&#x2013;5 ultrathin-section grids were examined and multiple microscopic fields (~10&#x2013;12 fields) were analyzed at the indicated magnifications. <bold>(A)</bold> Mitochondria <bold>(M)</bold> in uninfected HBMECs (x8000); <bold>(B)</bold> alterations in mitochondria at 4th hpi (x6000); <bold>(C)</bold> alterations in mitochondria at 18th hpi (x6000); <bold>(D)</bold> Golgi apparatus <bold>(G)</bold> in uninfected HBMECs (x10000); <bold>(E)</bold> alterations in Golgi at 4th hpi (x6000); <bold>(F)</bold> alterations in Golgi at 18th hpi (x8000); <bold>(G)</bold> Endoplasmic reticulum (ER) in uninfected HBMECs (x5000); <bold>(H)</bold> alterations in ER at 4th hpi (x6000); <bold>(I)</bold> alterations in ER at 18th hpi (x6000); <bold>(J)</bold> Nuclear morphology <bold>(N)</bold> in uninfected HBMECs (x1500); <bold>(K)</bold> alterations in nuclear morphology at 4th hpi (x2000); <bold>(L)</bold> alterations in nuclear morphology at 18th hpi (x500, x1200); <bold>(M)</bold> actin filaments (*) in uninfected HBMECs (x5000); <bold>(N)</bold> stress fibers (*) at 4th hpi (x4000); <bold>(O)</bold> stress fibers (*) at 18th hpi (x6000). <bold>(P)</bold> Vacuoles (V) within the host cell cytoplasm (x6000).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1735570-g002.tif">
<alt-text content-type="machine-generated">Electron micrographs display cellular structures labeled with letters. Images A, B, and C show mitochondria (M). Images D, E, and F depict Golgi apparatus (G). Images G, H, and I illustrate endoplasmic reticulum (ER). Images J, K, and L feature nuclei (N). Images M, N, O, and P highlight various detailed cellular features, with P showing a vesicle (V). Each micrograph provides detailed views of subcellular organelles with scale bars for reference.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_2_2">
<label>3.2.2</label>
<title>Golgi apparatus</title>
<p>In their non-infected state, HBMECs displayed the characteristic Golgi structure with flattened, membrane bound cisterns stacked in series along with budding vesicles (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2D</bold></xref>). However, at the 4th-hour time point after infection with <italic>Cryptococcus</italic>, there was a discernible but relatively minor alteration in the regular Golgi morphology (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2E</bold></xref>). A more significant change occurred by the end of the 18-hour infection period, characterized by marked dilation and fragmentation of the Golgi cisternae (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2F</bold></xref>). Portions of the Golgi apparatus appeared to have redistributed from their typical perinuclear location to positions closer to the periphery of the endothelial cell, becoming dispersed throughout the cell cytoplasm.</p>
</sec>
<sec id="s3_2_3">
<label>3.2.3</label>
<title>Endoplasmic reticulum</title>
<p>The Endoplasmic Reticulum (ER) in uninfected HBMECs exhibited regular morphology comprising flattened, interconnected membrane structures characterized with ribosomes on its cytoplasmic surface, which imparts a rough appearance when observed under an electron microscope (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2G</bold></xref>). However, following <italic>Cryptococcus</italic> infection, significant changes in the ER morphology became apparent. At the 4th-hour time point post-infection, the ER retained a structure resembling its typical appearance (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2H</bold></xref>). Nonetheless, by the end of 18-hour infection period, the ER underwent substantial fragmentation and dilation, accompanied by the formation of ER-derived vesicles. These ER fragments were found dispersed throughout the cellular cytoplasm. Notably, it was observed that the ribosomes present on the surface of the rough endoplasmic reticulum with dilated lumen, had become partially detached (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2I</bold></xref>) and appeared more similar to the smooth endoplasmic reticulum in its morphology. These structural alterations in the ER have the potential to significantly impact the cellular processes related to protein synthesis, folding, and post-translational modifications affecting the overall cellular homeostasis.</p>
</sec>
<sec id="s3_2_4">
<label>3.2.4</label>
<title>Nucleus</title>
<p>The nuclear morphology of HBMECs typically entails round to oval shape with a smooth and regular contour, along with a prominent nucleolus located within the nucleoplasm (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2J</bold></xref>). However, cryptococcal infection induced significant irregularities in the nuclear morphology of HBMECs. By the end of the 4th hpi, the nuclear shape exhibited alterations with the initiation of fragmentation, presenting multiple indentations (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2K</bold></xref>). By the 18th hpi, nuclear fragmentation had advanced, resulting in the presence of 2&#x2013;3 distinct fragments, each displaying an irregular morphology. Notably, the nuclear membrane was poorly defined and had suffered complete disruption (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2L</bold></xref>). Overall, the endothelial cells appeared to be undergoing early stages of apoptosis, reflecting the cellular response to the cryptococcal infection.</p>
</sec>
<sec id="s3_2_5">
<label>3.2.5</label>
<title>Cytoplasm</title>
<p>Generally, the cytoskeleton fibers are arranged in a parallel orientation along the length of the cell (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2M</bold></xref>). However, following infection their morphology and arrangement were altered. As the infection progressed, these fibers became denser and formed more compact bundles, with the effect being more pronounced at 18th hour (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2O</bold></xref>) time point compared to the 4th hpi (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2N</bold></xref>). The presence of vacuoles or membrane-bound compartments was observed within the host cell cytoplasm which could be formed as a result of altered metabolic processes or cellular stress induced by the infection (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2P</bold></xref>). Such vacuoles may contain various materials, including organelles, proteins, or pathogen-related components suggesting that the host may be attempting to restrict the pathogen's spread and limit its impact as a defensive mechanism.</p>
</sec>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Submicroscopic morphological modifications within HBMECs in response to clinical and environmental <italic>Cryptococcus</italic> isolates</title>
<p>The ultrastructural changes observed in HBMECs at the 4<sup>th</sup> and 18<sup>th</sup> hour time points following infection with clinical and environmental isolates of <italic>Cryptococcus</italic> yielded consistent and indistinguishable results. These degenerative changes displayed a resemblance in response of HBMECs to isolates from both the source, suggesting a parallel impact of <italic>Cryptococcus</italic> on subcellular morphology during the early and later phases of infection. The infected HBMECs exhibited initial signs of morphological modifications, relatively minor subcellular organelle alterations at 4<sup>th</sup> hpi. This early response was consistent across both clinical and environmental isolates, suggesting a commonality in the impact of <italic>Cryptococcus</italic> on subcellular morphology during the initial phases of infection. As the infection progressed to the 18th-hour time point, both clinical and environmental isolates induced severe subcellular organelle degenerative changes and dysfunction in HBMECs. These changes were uniform across <italic>Cryptococcus</italic> isolated from both clinical and environmental source, emphasizing the robustness of the host cell's response to the fungal infection. Membrane ruffling, extensive microvilli formation and autophagy were uniformly observed within HBMECs challenged with clinical and environmental <italic>Cryptococcus</italic> isolates, signifying a synchronized cellular response where the host attempts to counteract the infection.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Dual RNASeq of the infected host and the pathogen</title>
<p>Dual RNASeq is a powerful high through put omics approach to gauge the gene expression profiles simultaneously of the infecting pathogen and the host being infected. The quality of RNAs as estimated by Bioanalyzer calculating the RIN ranged from 8.4&#x2013;10 indicating least degraded and the most quality RNA. All the libraries yielded fragment size considered optimal, ranged from 289&#x2013;375 nt and the sequencing of each sixteen co-culture specimens in duplicates generated 25 &#x2013; 38.8 million reads. In total, 38,552; 1,014; and 763 genes were mapped to the human, <italic>C.neoformans</italic> and <italic>C.gattii</italic> reference genomes respectively. The analysis employed cut off of &#x2264; 0.05 for p-values, &#x2264; 0.05 for false discovery rate (FDR) and an absolute log2FoldChange value &#x2265; 1.5 for up regulated and &#x2264; -1.5 for down regulated significant profiling of the genes that are differentially expressed.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Evaluation of differential gene expression in HBMECs</title>
<p>To elucidate the gene expression responses exhibited by the host upon encountering the pathogen, sequenced reads from all the described eight co-culture categories were compared with the reads from the uninfected HBMECs. The comparative analysis revealed a range of DEGs encompassing diverse functional categories in the host (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>). Of the 3275 (CLCneo_T4), 4876 (CLCneo_T18), 2391 (CLCgattii_T4), 4031 (CLCgattii_T18), 5093 (ENCneo_T4), 5659 (ENCneo_T18), 6292 (ENCgattii_T4), 6790 (ENCgattii_T18) genes found to be differentially expressed in the host among the various treated categories; we found 335, 590, 136, 455, 470, 822, 804, 1148 significantly upregulated genes and 115, 125, 68, 115, 238, 265, 238, 346 significantly downregulated genes sequentially with respect to all the eight treated categories in response to the infecting pathogen on the basis of selection criteria for DEGs (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>    
<p>Volcano plot depicting the gene expression profiles of all the eight treated categories <bold>(A&#x2013;H)</bold>, where the variables passing both the statistical significance criteria with p-value cut off (&#x2264; 0.05) and Log2FC cut off (&#x2265; 1.5, &#x2264; -1.5) are represented in red. The challenged HBMECs as described under <xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref> <bold>(A&#x2013;H)</bold> was compared to the uninfected HBMECs (host) to profile the various differentially expressed genes during the event of host and the pathogen interaction measured at two different time points (T4 and T18) <italic>in vitro</italic>. The data shown are representative of duplicate independent RNA-Seq experiments conducted under identical experimental conditions.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1735570-g003.tif">
<alt-text content-type="machine-generated">Eight volcano plots labeled A to H, each displaying Log2 fold change on the X-axis against negative Log10 p-value on the Y-axis. Data points are colored by significance: green for non-significant, gray for Log2 fold change, blue for p-value, and red for both p-value and Log2 fold change.</alt-text>
</graphic></fig>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Venn diagram visually displaying the shared and unique sets of differentially expressed up-regulated <bold>(A)</bold> (4th hpi) <bold>(C)</bold> (18th hpi)] and down-regulated <bold>(B)</bold> (4th hpi) <bold>(D)</bold> (18th hpi)] genes in HBMECs (host) obtained by comparing all the eight challenged categories with uninfected HBMECs describing the common and distinct DEGs across different comparison categories. The non-overlapping numbers represent elements unique to each condition while the overlapping ones signify mutually shared DEGs among the various comparison entities. The data shown are representative of duplicate independent RNA-Seq experiments conducted under identical experimental conditions.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1735570-g004.tif">
<alt-text content-type="machine-generated">Four Venn diagrams labeled A to D compare gene expression changes across different conditions. Each diagram shows overlapping areas with numbers and percentages indicating shared and unique gene expressions among conditions. Different colors represent the conditions: HB-MEC_ENC, HB-MEC_CLCG, HB-MEC_CLCneo, and HB-MEC_ENCG, each with upregulation (Up) or downregulation (Dn) statuses.</alt-text>
</graphic></fig>
<p>Infection of HBMECs with clinical and environmental isolates of <italic>C.neoformans</italic> and <italic>C.gattii</italic> resulted in 49 (5.1%) and 239 (16.8%) commonly upregulated genes at time points T4 and T18, respectively. Similarly, 17 (4.4%) and 31 (5.8%) genes exhibited common downregulation at T4 and T18 time points. Furthermore, the comparative analysis led to the identification of uniquely up and down regulated elements among all the eight infected co-culture categories: 47 (4.9%), 67 (4.7%), 35 (3.6%), 52 (3.7%), 63 (6.5%), 112 (7.9%), 315 (32.6%), 326 (23%) and 28 (7.2%), 27 (5.1%), 33 (8.5%), 50 (9.4%), 71 (18.3%), 87 (16.4%), 69 (17.8%), 157 (29.5%) respectively in comparison with the non-infected HBMECs (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>). The genes displaying differential expression were categorized into three primary functional Gene Ontology groups namely biological processes, cellular components, and molecular functions.</p>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Gene ontology enrichment analysis of DEGs in HBMECs</title>
<p>The functional enrichment analysis of genes differentially expressed at the early infection time point (4 hrs) revealed enrichment in several biological processes and molecular functions with genes coding for proteins involved in integrin-mediated cell adhesion (VTN, ITGB3, ITGB8, EMILIN2, FBN1), immune responses (CCL5, TNFSF13, IFITM2, ITGB8, C3, TRIM22), reactions to toxic substances (ADAMTS13, CCL5, CYP1B1, NUPR1, SLC7A11), regulation of macrophage chemotaxis (CCL5, IL34, TRPV4), apoptotic processes (BACE1, DDIT3, GRIK5, PCSK9, NUPR1, BBC3), autophagy-related functions (DDIT3, TP53INP1, RAB39B, TRIB3, NUPR1), T-cell migration (CCL5, DOCK8, ITGB3, TNFRSF14), control of angiogenesis (PTGIS, HSPB6, ADM2, ITGB3, ITGB8, EMILIN2, CYP1B1, TLR3, RAPGEF3, AQP1, VEGFA), cellular responses to hypoxia (VCAM1, MB, DDIT4, SLC2A1, CYP1A1, MTHFR, CA9, ABAT, CRYAB, LOXL2, VEGFA), and glycolytic processes (ACTN3, DDIT4, NUPR1).</p>
<p>Notably, the cellular response to interleukin 1, IL-2, IL-9, IL-15, and IL-4 exhibited significant upregulation in the host as an initial reaction to the invading fungal pathogen. In Ambrose Jong et&#xa0;al.'s time-course study, a genomic analysis of HBMECs infected with <italic>C.neoformans</italic> showed consistent alterations in MHC gene expression throughout the interactions at all stages, suggesting that host cells undergo significant gene profile changes and play an active role in CNS immunoregulation during <italic>C.neoformans</italic> infection (<xref ref-type="bibr" rid="B33">Jong et&#xa0;al., 2008</xref>).</p>
<p>As depicted in <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5</bold></xref>, genes associated with response to amphetamine show significant downregulation, emphasizing the host&#x2019;s defense against fungal infection. Previous research has demonstrated that amphetamine disrupts BBB integrity and alters the expression of tight junction and adhesion molecules, thereby increasing susceptibility to CNS infections. This disruption of the blood brain barrier accelerates transmigration of the neurotropic fungus <italic>Cryptococcus</italic> spp into the brain parenchyma following systemic infection (<xref ref-type="bibr" rid="B12">Eugenin et&#xa0;al., 2013</xref>). Similarly, our study elucidates that the host responds to the infection by preserving the integrity of endothelial tight junctions, suggesting that it does not compromise BBB integrity and thus safeguards the brain from infection.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Gene Ontology representation of differentially expressed genes enriched in the host (HBMECs) during <italic>in vitro</italic> infection with the fungal pathogen <italic>C neoformans/gattii</italic> species complex, sourced from both clinical and environmental origins <bold>(A&#x2013;D)</bold>. X-axis represents the fold enrichment of each GO terms. <bold>(A)</bold> Significant upregulated GO terms enriched in co-culture categories at T4 <bold>(B)</bold> Significant downregulated GO terms enriched in co-culture categories at T4 <bold>(C)</bold> Significant upregulated GO terms enriched in co-culture categories at T18 <bold>(D)</bold> Significant downregulated GO terms enriched in co-culture categories at T18. The data shown are representative of duplicate independent RNA-Seq experiments conducted under identical experimental conditions.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1735570-g005.tif">
<alt-text content-type="machine-generated">Bar charts labeled A, B, C, and D, display GO term enrichment divided into biological process, cellular component, and molecular function, color-coded in purple, green, and red respectively, representing different fold enrichment values. Each chart highlights variations in enrichment levels across these categories.</alt-text>
</graphic></fig>
<sec id="s3_6_1">
<label>3.6.1</label>
<title>Gene expression associated with alterations in the cellular components</title>
<p>We observed that the interaction between <italic>Cryptococcus</italic> and HBMECs within the controlled environment exhibits a complex interplay characterized by remarkable alterations in the expression profiles of genes linked to diverse cellular components. Notably, there were significant alterations in the genes associated with extracellular matrix organization, plasma membrane, Golgi, endoplasmic reticulum (ER) and nuclear component (<xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref>). This finding aligns with the study conducted by Chen et&#xa0;al. which demonstrated that <italic>C.neoformans</italic> induces alterations in the cytoskeleton of human brain microvascular endothelial cells (<xref ref-type="bibr" rid="B6">Chen et&#xa0;al., 2003</xref>), either as the host&#x2019;s effort to recognize and respond to the pathogen or the pathogen driven cellular modifications for its own advantage in the hostile environment.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>showing the enriched Gene Ontology terms derived from the list of differentially expressed genes associated with the alterations in the diverse cellular components within the host (HBMECs) during the early stage (4 hours) of <italic>in vitro</italic> infection with the fungal pathogen <italic>C.neoformans/gattii</italic> species complex, sourced from both clinical and environmental origins.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Cellular Component GO terms</th>
<th valign="middle" align="center">Genes</th>
<th valign="middle" align="center">Fold Enrichment</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="middle" colspan="3" align="left">UPREGULATION</th>
</tr>
<tr>
<td valign="middle" align="left">extracellular matrix</td>
<td valign="middle" align="left">SNED1, POSTN, LRRC24, ELN, BGN, TNFRSF11B, FBLN2, ADAMTS10, RELN, ADAMTS13, EMID1, FBN1, TECTA</td>
<td valign="middle" align="center">5.25</td>
</tr>
<tr>
<td valign="middle" align="left">microvillus membrane</td>
<td valign="middle" align="left">SLC7A5, SYTL1, CA9, S100P, SLC7A11</td>
<td valign="middle" align="center">15.78</td>
</tr>
<tr>
<td valign="middle" align="left">plasma membrane</td>
<td valign="middle" align="left">SLC48A1, IFITM1, IFITM2, GRIK5, MPL, TBC1D3E, SLC2A3, SLC7A11, MYPN, BEST1, UPK1A, OLR1, CA9, JAK3, TECTA, PAQR8, ENTPD2, UNC5B, ARRDC3, SYTL1, ISLR2, CACNA2D2, RUNDC3A, PRLR, GABRG1, SLC7A5, ALDH3A1, GPRIN2, PTP4A3, DOK7, SCNN1A, ORAI3, TRIB3, CFB, SLC47A2, PMEL, CALCRL, EPHA10, NPR1, HTRA1, SLC1A4, TNFRSF11B, SLC3A2, C3, RASD2, RELN, ERBB4, ALDH3B1, CPAMD8, REPS2, NPTX1, GRIA4, STRA6, SYT5, LIMS3, COL26A1, IFITM10, CARMIL3, TNFRSF9, HSPA6, GABRA3, SLC52A1, CP, TMEM198, SLC6A9, SYT12, FXYD2, OR2A7, MDGA1, GPR146</td>
<td valign="middle" align="center">1.37</td>
</tr>
<tr>
<td valign="middle" align="left">cell surface</td>
<td valign="middle" align="left">LRRC24, MPL, BGN, ISLR2, SLC1A4, SLC3A2, SLC7A11, PRLR, C3, UPK1A, ADAMTS13, PSG5, BSN</td>
<td valign="middle" align="center">2.07</td>
</tr>
<tr>
<td valign="middle" align="left">endoplasmic reticulum lumen</td>
<td valign="middle" align="left">C3, COL26A1, ADAMTS13, H6PD, STC2, IGFBP3, CP, FBN1</td>
<td valign="middle" align="center">2.71</td>
</tr>
<tr>
<td valign="middle" align="left">exocytic vesicle</td>
<td valign="middle" align="left">SYT5, SYT12, SYTL1</td>
<td valign="middle" align="center">11.16</td>
</tr>
<tr>
<td valign="middle" align="left">melanosome</td>
<td valign="middle" align="left">PMEL, SYTL1, SLC3A2, SLC1A4</td>
<td valign="middle" align="center">4.01</td>
</tr>
<tr>
<td valign="middle" align="left">fibrinogen complex</td>
<td valign="middle" align="left">FGB, FGG, FN1</td>
<td valign="middle" align="center">27.43</td>
</tr>
<tr>
<td valign="middle" align="left">microfibril</td>
<td valign="middle" align="left">EFEMP2, ADAMTS10, FBN1</td>
<td valign="middle" align="center">16.88</td>
</tr>
<tr>
<td valign="middle" align="left">perikaryon</td>
<td valign="middle" align="left">GRIK5, SLC2A3, KLHL24, SYNPO, CRYAB, SLC8A2</td>
<td valign="middle" align="center">2.73</td>
</tr>
<tr>
<td valign="middle" align="left">Golgi lumen</td>
<td valign="middle" align="left">MMP11, VTN, MUC1, MUC16, F10, PDGFB, BGN, PCSK6</td>
<td valign="middle" align="center">3.19</td>
</tr>
<tr>
<td valign="middle" align="left">lamin filament</td>
<td valign="middle" align="left">NARF, LMNTD2</td>
<td valign="middle" align="center">23.71</td>
</tr>
<tr>
<td valign="middle" align="left">neuron projection</td>
<td valign="middle" align="left">RELN, EPHA10, AVIL, GABRA3, CHAT, MPL, OPRL1, RAB39B, RGS11, MCHR1, EPHA3</td>
<td valign="middle" align="center">1.77</td>
</tr>
<tr>
<th valign="middle" colspan="3" align="left">DOWNREGULATION</th>
</tr>
<tr>
<td valign="middle" align="left">fat cell differentiation</td>
<td valign="middle" align="left">NR4A2, NR4A1, EGR2, NR4A3</td>
<td valign="middle" align="center">12.77</td>
</tr>
<tr>
<td valign="middle" align="left">focal adhesion</td>
<td valign="middle" align="left">BCAR3, EFNB2, MME, PLAUR, NEXN, LCP1, PFN1, CORO2B, TGM2</td>
<td valign="middle" align="center">2.29</td>
</tr>
<tr>
<td valign="middle" align="left">secretory granule</td>
<td valign="middle" align="left">SRGN, PTPRN2, SCG5, CFP</td>
<td valign="middle" align="center">4.50</td>
</tr>
<tr>
<td valign="middle" align="left">transcription factor complex</td>
<td valign="middle" align="left">NR4A2, NR4A1, JUN, NR4A3, FOS, HDAC9</td>
<td valign="middle" align="center">2.83</td>
</tr>
<tr>
<td valign="middle" align="left">cell-cell junction</td>
<td valign="middle" align="left">COL17A1, COL13A1, LAMA1, PTPN6, STEAP1</td>
<td valign="middle" align="center">2.86</td>
</tr>
<tr>
<td valign="middle" align="left">microtubule cytoskeleton</td>
<td valign="middle" align="left">TUBA1C, TUBA1B, PLK1, TUBB4B, HYPK, TUBA4A, TUBA8</td>
<td valign="middle" align="center">2.98</td>
</tr>
<tr>
<td valign="middle" align="left">actin cytoskeleton</td>
<td valign="middle" align="left">CD274, SMTN, MYO5B, NEXN, SPTB, CORO2B, CORO1A, BCAR1</td>
<td valign="middle" align="center">2.46</td>
</tr>
<tr>
<td valign="middle" align="left">chromatin</td>
<td valign="middle" align="left">NR4A2, EGR1, NR4A1, EGR2, HMGN5, NR4A3, CREB3L3, FOSB, DPF3, HES1, FOS, TGM2</td>
<td valign="middle" align="center">2.87</td>
</tr>
<tr>
<td valign="middle" align="left">membrane raft</td>
<td valign="middle" align="left">TLR1, MME, PODXL, S1PR1, CD226, TLR6, NTSR1</td>
<td valign="middle" align="center">3.12</td>
</tr>
<tr>
<td valign="middle" align="left">phagocytic cup</td>
<td valign="middle" align="left">TICAM2, PEAR1</td>
<td valign="middle" align="center">23.38</td>
</tr>
<tr>
<td valign="middle" align="left">nucleoplasm</td>
<td valign="middle" align="left">EGR1, EGR2, DUSP2, NPIPA8, FOS, PWP2, PTHLH, NR4A2, NR4A1, FOSB, HES1, PTPN6, JUNB, IER2</td>
<td valign="middle" align="center">1.79</td>
</tr>
<tr>
<td valign="middle" align="left">cytoplasm</td>
<td valign="middle" align="left">EGR1, ABHD14A-ACY1, EGR2, DUSP2, BCL2A1, DUSP1, FAXC, PTHLH, NR4A2, NR4A1, RGS2, PDZD2, HES1, PTPN6, PPIAL4G, IER2</td>
<td valign="middle" align="center">1.45</td>
</tr>
<tr>
<td valign="middle" align="left">podosome</td>
<td valign="middle" align="left">AFAP1L1, LCP1, FERMT3</td>
<td valign="middle" align="center">11.72</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The extracellular matrix (ECM) serves as a critical interface for host-pathogen interactions influencing cellular adhesion, migration and signaling. The substantial changes observed in the ECM associated genes suggest that <italic>Cryptococcus</italic> may attempt to modulate cellular adhesion and thereby facilitate its adherence to HBMECs. Alterations in the genes related to the plasma membrane, which plays a central role in sensing extracellular cues may indicate either <italic>Cryptococcus</italic> driven modifications of the membrane structure or the host&#x2019;s effort to recognize and respond to the pathogen&#x2019;s presence. The changes in genes linked to ER and Golgi signifies modulations in protein processing and transportation, potentially reflecting the host&#x2019;s infection induced stress or the pathogen&#x2019;s manipulation of cellular trafficking for its own benefits. Furthermore, observed alterations in the nuclear gene expression points to the host&#x2019;s attempt to initiate transcriptional responses to trigger immune activation or the pathogen&#x2019;s manipulation to host signaling pathways to its advantage.</p>
<p>A noteworthy observation in our study was the significant expression levels of melanosomes in HBMECs upon encountering the pathogen <italic>Cryptococcus</italic>. Melanosomes known for melanin production in melanocytes was traditionally thought to be limited to melanocytes. While recent research has revealed the presence of melanosomes in other cell types such as certain immune cells and even microvascular endothelial cells (<xref ref-type="bibr" rid="B76">Yamaguchi and Hearing, 2014</xref>; <xref ref-type="bibr" rid="B61">Regazzetti et&#xa0;al., 2015</xref>). Melanocytes, in addition to being melanin factories, they apparently play a key role as the first line of innate immune defense against fungal infections in association with the activation of TLRs (<xref ref-type="bibr" rid="B68">Tapia et&#xa0;al., 2014</xref>). In the context of <italic>Cryptococcus</italic> infecting HBMECs, the positive regulation of melanosomes could potentially contribute to the host&#x2019;s defense by producing melanin as a counter measure against the pathogen&#x2019;s virulence mechanisms. On the other hand melanin production stands out as a key virulence factor in <italic>Cryptococcus</italic> species which helps to evade host immune responses by dampening the oxidative stress inflicted by immune cells and also aids in immune cell avoidance allowing it to establish infection and persist within the human host (<xref ref-type="bibr" rid="B45">Liu et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s3_6_2">
<label>3.6.2</label>
<title>Dual regulation of essential genes</title>
<p>In the process of functional enrichment analysis, another significant observation pertained to the dual regulation of specific essential genes associated with cellular components, immune responses and cell signaling pathways during <italic>Cryptococcus</italic>-HBMEC interaction at early and late infection time points (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5</bold></xref>). The differential expression of host genes during the complex interplay between <italic>Cryptococcus</italic> and HBMECs reflects the intricate regulatory network that <italic>Cryptococcus</italic> engages to adapt to the hostile environment presented by the immune system (<xref ref-type="bibr" rid="B39">Kronstad et&#xa0;al., 2012</xref>). The simultaneous upregulation and downregulation of specific genes reflect underlying gene regulatory mechanisms where <italic>Cryptococcus</italic> employs versatile adaptation strategies to evade host immune responses and ensure its survival within the host immune cells. However, in the context of the BBB and brain, heightened inflammation can compromise barrier integrity, facilitating further pathogen invasion and exacerbating tissue damage. This dual regulation of GO terms in challenged HBMECs highlights the complexity and context-dependent nature of host-pathogen interactions underscoring the host&#x2019;s attempt to strike a balance between mounting an immune response and the avoidance of excessive inflammation and tissue damage (<xref ref-type="bibr" rid="B8">Cicchese et&#xa0;al., 2018</xref>).</p>
</sec>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Enrichment analysis of pathways for identified DEGs in challenged HBMECs</title>
<p>Further on to understand the molecular strategies and immune responses during infection, we analyzed KEGG pathway enrichment using DAVID, which revealed the profound association of upregulated DEGs with multiple pathways including PI3K-Akt, p53, cGMP-PKG, cAMP, MAPK, HIF-1, calcium signaling pathways. Additionally, these upregulated DEGs were found to be linked with cytokine-cytokine receptor interaction, Neuroactive ligand receptor interaction, ECM-receptor interaction and focal adhesion pathways. Conversely, the downregulated DEGs exhibited enrichment in IL-17, NF-kappa B, TNF, cAMP, JAK-STAT, MAPK, PI3K-Akt, Toll- like, NOD-like, B- cell receptor signaling pathways and osteoclast differentiation (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6</bold></xref>). The JAK-STAT pathway functions as the primary signaling mechanism for a multitude of cytokines including interferon, interleukins and growth factors and plays a crucial role in host defense and immune-regulation. A significant regulatory function of the phosphatidylinositol 3-kinase (PI3K) dependent extracellular signal regulated kinase 1/2 (ERK1/2) signaling pathway involves exhibiting antimicrobial activity against the yeast <italic>Cryptococcus</italic> (<xref ref-type="bibr" rid="B72">Voelz and May, 2010</xref>). In the context of integration between the major cell signaling pathways like JAK/STAT, MAPK, PI3K-dependent ERK1/2 exerts a profound impact on the immune response (<xref ref-type="bibr" rid="B60">Rawlings et&#xa0;al., 2004</xref>) and contributes in the phenomenon of combating cryptococcal infection by facilitating critical cellular processes for pathogen recognition and phagocytosis by playing a central role in orchestrating cytokine production (<xref ref-type="bibr" rid="B77">Yang et&#xa0;al., 2022</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Bar plot representing the crucial function of differentially expressed essential genes obtained through pathway analysis using KEGG (Kyoto Encyclopedia of Genes and Genomes) enriched in the host (HBMECs) during interaction with the pathogen C <italic>neoformans/gattii</italic> species complex, isolated from both clinical and environmental sources. Few top listed significant pathways enriched from the upregulated DEGs are depicted in light blue at the top, while those enriched from the downregulated DEGs are presented in dark blue at the bottom. <bold>(A)</bold> Pathways enriched at early time point (T4) <bold>(B)</bold> Pathways enriched at later time point (T18). The data shown are representative of duplicate independent RNA-Seq experiments conducted under identical experimental conditions.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1735570-g006.tif">
<alt-text content-type="machine-generated">Two bar charts labeled A and B compare fold enrichment of different biological pathways. Chart A and B each have lists of pathways on the left, with blue and green bars extending horizontally to the right, representing different fold enrichment levels. Both charts have scales at the bottom indicating fold enrichment values up to 15 for A and up to 6 for B.</alt-text>
</graphic></fig>
<p>These signaling pathways are interconnected forming a complex regulatory network that collaboratively coordinates the host&#x2019;s defense mechanisms against the invading fungal pathogen. Infection with <italic>Cryptococcus</italic> stimulates the differentiation of Th17 cells resulting in the secretion of IL-17 which is regulated by activated CD4+T cells stimulated JAK/STAT signaling pathway there by exhibiting a profound mechanism of antifungal immunity (<xref ref-type="bibr" rid="B26">Guo et&#xa0;al., 2022</xref>). During fungal invasion, the host recognizes pathogen-associated molecular patterns (PAMPs) through Toll-like receptors (TLRs) and Nucleotide-binding oligomerization domain-like receptors (NLRs), initiating the Toll-like and NOD-like pathways, respectively, triggering a cascade of events, including the activation of NF-kappa B and MAPK pathways, leading to the production of several pro-inflammatory cytokines. Concurrently, phosphatidylinositol 3-kinase (PI3K-Akt) signaling pathway influences melanin production contributing to the pathogenesis of <italic>Cryptococcus</italic> spp complex (<xref ref-type="bibr" rid="B38">Kozubowski et&#xa0;al., 2009</xref>). Similarly, cAMP, cGMP-PKG, neuroactive ligand receptor signal transduction pathways promotes metabolism, cell proliferation, growth, cell survival and angiogenesis contributing to regulate the adaptive immune activation against infection.</p>
<p>Hypoxia-inducible factor-1 (HIF-1), triggered by hypoxia in the mammalian host, constitutes a key component of the prominent pathways engaged in innate immune responses against fungal infections (<xref ref-type="bibr" rid="B19">Friedrich et&#xa0;al., 2017</xref>). Upon encountering various cellular stress factors such as DNA damage, in response to which p53, a nuclear transcription factor gets activated in the host promoting its pro-apoptotic function. Activated p53 pathway is involved in DNA repair, senescence, cell cycle arrest and apoptosis by transactivating target genes triggering the cellular responses to limit the spread of infection (<xref ref-type="bibr" rid="B53">Ozaki and Nakagawara, 2011</xref>). In connection to this, in our investigation, we observed significant enrichment of the p53 pathway with a marked increase in fold change from early to later infection time points. This enrichment effectively halts damaged cell propagation, thus impeding the transmission of impaired DNA to daughter cells. Strikingly, enrichment of ferroptosis related process, a distinct form of cell death driven by lipid peroxidation and iron accumulation represents a potential regulatory mechanism associated with infectious diseases like cryptococcal meningitis suggesting a dynamic interaction between pro-apoptotic responses and cell death modalities to counteract the propagation of damaged cells and prevent the transfer of compromised genetic material (<xref ref-type="bibr" rid="B73">Xiao et&#xa0;al., 2022</xref>).</p>
<sec id="s3_7_1">
<label>3.7.1</label>
<title>Dual regulation of gene expression by immediate early genes</title>
<p>When analyzing changes in gene expression to understand how the host responds to the pathogen and how the pathogen manipulates the host's cellular processes in an <italic>in vitro</italic> setting, specific signaling pathways and molecular mechanisms were identified to be enriched among the down regulated differentially expressed genes as depicted in <xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6</bold></xref>. In response to a diverse array of pathophysiological or infectious stimuli, CNS can initiate the expression of immediate early genes (IEGs) which can subsequently repress their own transcription through negative feedback mechanisms (<xref ref-type="bibr" rid="B3">Akins et&#xa0;al., 1996</xref>). In our study, the prototype members of IEGs namely FOS, FOSB, FOSL1, JUN, NR4A1, EGR1, EGR2 were found to exhibit notable expression across critical signaling pathways. Notably, these IEGs function as dual-role transcription factors that are capable of both activating and repressing gene expression depending on the cellular context and the specific binding partners they interact with (<xref ref-type="bibr" rid="B22">Gius et&#xa0;al., 1990</xref>). The tug&#x2013;of&#x2013;war between host and the pathogen triggers a switch in the complex network of signaling pathways involving a rapid induction followed by suppression of key immune pathways as part of a regulatory feedback loop during specific stages of the infection. This dual functionality empowers IEGs to regulate a broad spectrum of biological processes in response to various stimuli.</p>
</sec>
<sec id="s3_7_2">
<label>3.7.2</label>
<title>Anticryptococcal therapeutic targets</title>
<p>The functional enrichment analysis revealed the enrichment of specific pathways namely histidine metabolism, ferroptosis, IL-17 and RAS signaling pathways that displays antimicrobial activity. The anticryptococcal mechanism driven by enriched histidine metabolism in HBMECs during infection with <italic>Cryptococcus</italic> spp complex <italic>in vitro</italic> is potentiated by low pH and thereby contributes to maintaining cellular pH homeostasis creating an unfavorable environment for cryptococcal survival and proliferation (<xref ref-type="bibr" rid="B34">Kacprzyk et&#xa0;al., 2007</xref>). In addition, histidine metabolism contribute to the production of reactive oxygen species (ROS) and other free radicals, having detrimental effects on the pathogen's cellular components aimed at impeding the growth and survival of the pathogen (<xref ref-type="bibr" rid="B29">Helmerhorst et&#xa0;al., 2001</xref>). Cationic amino acids like histidine containing natural peptides such as histatins and clavanins, presents an alternative approach for the advancement of novel antifungals, commonly referred to as cationic antimicrobial peptides (CAMPs). These peptides possess a positive charge and exhibits preferential binding affinity towards negatively charged fungal membranes, typically exerting their mechanism of action through membrane penetration and the disruption of pathogenic cells (<xref ref-type="bibr" rid="B1">Aaghaz et&#xa0;al., 2023</xref>).</p>
<p>Ferroptosis, a form of programmed cell death characterized by its dependence on iron and lipid peroxidation, plays a pivotal role in triggering immunogenic and proinflammatory responses. This is attributed to the release of damage-associated molecular pattern molecules (DAMPs) and alarmins by ferroptotic cells, resulting in a distinct mode of regulatory cell death in infectious diseases like cryptococcal meningitis. The lipid-rich nature of <italic>Cryptococcus</italic> membranes makes them particularly susceptible to ferroptosis-like mechanisms that disrupt lipid bilayers, causing cell rupture. Ferroptosis is intricately dependent on reactive oxygen species and iron, with disruption in intracellular iron metabolism or glutathione peroxidation pathways resulting in lipid reactive oxygen species accumulation and subsequent cell death. The potential involvement of ferroptosis in the pathogenesis of infectious diseases, such as cryptococcal meningitis, offers a novel avenue for therapeutic intervention, suggesting the exploration of more potent adjuvant treatments against cryptococcal meningitis (<xref ref-type="bibr" rid="B75">Xu et&#xa0;al., 2021</xref>).</p>
<p>Previous research has demonstrated that the IL-17 pathway governs antifungal immunity by inducing the upregulation of pro-inflammatory cytokines like IL-6, neutrophil-recruiting chemokines such as CXCL1 and CXCL5, and antimicrobial peptides like defensins, collectively working to constrain fungal overgrowth (<xref ref-type="bibr" rid="B9">Conti and Gaffen, 2015</xref>). Our study aligns with these findings, as we observed the enrichment of the IL-17 signaling pathway in HBMECs during <italic>Cryptococcus</italic> infection, associated with the regulation of proinflammatory cytokines including CXCL6, IL6, CXCL8, CXCL1, CXCL3, CXCL2, CCL20, and IL1B. This enrichment holds promise for therapeutic strategies against infectious diseases like cryptococcal meningitis. Through an <italic>in vitro</italic> mechanistic study, it was shown that activated CD4+ T cells were the primary source of IL-17 production, and Th17 cell differentiation was modulated by diverse signaling pathways, with the JAK2/STAT3 pathway playing a pivotal role. This study also underscores the significance of CD4+ T cells in antifungal immunity, suggests IL-17 as a diagnostic biomarker for cryptococcal infection, and proposes STAT3 as a potential target for antifungal therapies (<xref ref-type="bibr" rid="B26">Guo et&#xa0;al., 2022</xref>).</p>
<p>Another noteworthy observation in our study is the enrichment of Ras protein signaling pathway which is commonly associated with cellular growth, proliferation and survival. However, the activation of this pathway can indirectly contribute to antifungal defense mechanisms within the host in response to fungal infections including those caused by <italic>Cryptococcus</italic> species. Considering its involvement in the virulence and pathogenic characteristics of various yeast and fungal species, Ras protein signaling pathway upholds promise as a potential antifungal drug target (<xref ref-type="bibr" rid="B15">Fortwendel, 2012</xref>). Additionally, studies have demonstrated that modulating Ras signaling serves as a critical regulatory node for triggering apoptosis in the budding yeast <italic>S. cerevisiae</italic> (<xref ref-type="bibr" rid="B24">Gourlay and Ayscough, 2005</xref>; <xref ref-type="bibr" rid="B25">Gourlay and Ayscough, 2006</xref>; <xref ref-type="bibr" rid="B41">Leadsham et&#xa0;al., 2009</xref>) and <italic>C. albicans</italic> (<xref ref-type="bibr" rid="B57">Phillips et&#xa0;al., 2006</xref>). These findings further imply that pharmacological alterations of Ras protein signaling could be of considerable advantage to induce yeast cell death. While some current antifungals indirectly affect fungal Ras signaling, like amphotericin B that enters fungal membranes containing ergosterol, creating aqueous pores, causing localized thinning of the bilayer and thereby compels lipid-anchored Ras proteins into sterol-rich lipid rafts, facilitating their interactions with downstream proteins and promoting the initiation of signaling pathways. Pharmacologically manipulated enhanced Ras protein signaling triggers yeast apoptosis and oxidative damage by the production of reactive oxygen species via the cAMP-PKA pathway (<xref ref-type="bibr" rid="B54">Pentland et&#xa0;al., 2018</xref>).</p>
</sec>
</sec>
<sec id="s3_8">
<label>3.8</label>
<title>Fungal transcriptomic responses and virulence-associated pathways</title>
<p>We investigated the early and late differential gene expression changes exhibited by the fungal pathogen <italic>C.neoformans/ gattii</italic> spp complex isolated from the clinical and environmental sources during <italic>in vitro</italic> infection of HBMECs. The pathogen appears to adopt strategic mechanisms to enhance resistance against host immune defenses, which are key determinants of its virulence. To understand the gene expression responses elicited by the pathogen during host interaction we compared pathogen-derived reads from all eight treated co-culture categories described above (<xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>) against their corresponding isolates grown in laboratory culture medium.</p>
<p>In <italic>Cryptococcus</italic>, mapped reads ranged between 0.07% &#x2013; 0.15% when aligned to the custom built reference genome from fungi ensemble. This low mapping rate aligns with the findings from previous dual RNA-Seq studies and supports the consistency of our results (<xref ref-type="bibr" rid="B55">Petrucelli et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B28">Hayward et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B46">L&#xf3;pez-Agudelo et&#xa0;al., 2022</xref>). This comparative analysis revealed a range of genes found to be differentially expressed in the pathogen across treated co-culture groups as shown in <xref ref-type="table" rid="T4"><bold>Table&#xa0;4</bold></xref>. We characterized the significant up and down regulated genes by Gene Ontology functional classification database using FungiFun2 and found 25 most significant enriched categories among all eight treated groups involved in diverse biological processes, metabolism and cellular remodeling (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7</bold></xref>).</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Considerable range of differentially expressed genes in the pathogen across various treated co-culture categories in comparison with the laboratory media control.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Treated conditions</th>
<th valign="middle" align="center">Up regulated gene</th>
<th valign="middle" align="center">Down regulated gene</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">CLCneo_T4</td>
<td valign="middle" align="center">34</td>
<td valign="middle" align="center">25</td>
</tr>
<tr>
<td valign="middle" align="center">CLCneo_T18</td>
<td valign="middle" align="center">64</td>
<td valign="middle" align="center">39</td>
</tr>
<tr>
<td valign="middle" align="center">CLCgattii_T4</td>
<td valign="middle" align="center">03</td>
<td valign="middle" align="center">545</td>
</tr>
<tr>
<td valign="middle" align="center">CLCgattii_T18</td>
<td valign="middle" align="center">03</td>
<td valign="middle" align="center">573</td>
</tr>
<tr>
<td valign="middle" align="center">ENCneo_T4</td>
<td valign="middle" align="center">04</td>
<td valign="middle" align="center">706</td>
</tr>
<tr>
<td valign="middle" align="center">ENCneo_T18</td>
<td valign="middle" align="center">05</td>
<td valign="middle" align="center">593</td>
</tr>
<tr>
<td valign="middle" align="center">ENCgattii_T4</td>
<td valign="middle" align="center">04</td>
<td valign="middle" align="center">444</td>
</tr>
<tr>
<td valign="middle" align="center">ENCgattii_T18</td>
<td valign="middle" align="center">21</td>
<td valign="middle" align="center">129</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The analysis employed cut off of &#x2264; 0.05 for p-values, &#x2264; 0.05 for false discovery rate (FDR) and an absolute log2FoldChange value &#x2265; 1.5 for up regulated and &#x2264; -1.5 for down regulated significant profiling of the genes that are differentially expressed.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Functional categorization of differentially expressed genes derived from the fungal pathogen <italic>Cryptococcus neoformans/ gattii</italic> species complex originating from both clinical and environmental sources. The categorization was conducted across eight described treated co-culture conditions by Gene Ontology database using FungiFun2 tool, showcasing the 25 most significantly enriched categories within each group. The selection criterion to sort the DEGs considered the cut off of &#x2264; 0.05 for p-values, &#x2264; 0.05 for FDR and an absolute log2FoldChange value &#x2265; 1.5 for up regulated and &#x2264; -1.5 for down regulated DEGs. The data shown are representative of duplicate independent RNA-Seq experiments conducted under identical experimental conditions.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1735570-g007.tif">
<alt-text content-type="machine-generated">A series of twelve pie charts titled CLCneo_T4, CLCneo_T18, CLCgattii_T4, CLCgattii_T18, ENCneo_T4, ENCneo_T18, ENCgattii_T4, and ENCgattii_T18. Each chart displays various colored segments representing different biological processes, activities, or components. Each segment is labeled and accompanied by a color-coded legend beneath each chart for identification. Numbers on the pie charts indicate the proportion of each category.</alt-text>
</graphic></fig>
<p>The Gene Ontology functional enrichment analysis revealed critical biological processes and pathways contributing to the virulence and pathogenicity of <italic>Cryptococcus</italic> species complex. One of the significant findings was the enrichment of genes related to cytoskeleton organization and autophagy. The importance of the WASH complex, necessary for autophagosome formation, was highlighted. Autophagy, a degradative pathway, plays a crucial role in recycling cellular components and providing amino acids essential for survival, particularly under stress conditions (<xref ref-type="bibr" rid="B37">King et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B31">Jiang et&#xa0;al., 2020</xref>).</p>
<p>The study emphasized the role of genes involved in cell wall remodeling, carbohydrate and nitrogen metabolism, Ubiquitin mediated proteolysis, metabolite and energy generation, and mitochondrial organization. These processes are essential for establishing and progressing infections, as well as modulating the production and activity of virulence factors, such as fungal cell wall structure and melanin (<xref ref-type="bibr" rid="B63">Ries et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B4">Cao and Xue, 2021</xref>). Ribosomal modulation and proteasome activity were found to be vital for the degradation of cellular proteins and the synthesis of the polysaccharide capsule in <italic>Cryptococcus</italic> during the early stages of infection (<xref ref-type="bibr" rid="B18">Freitas et&#xa0;al., 2022</xref>).</p>
<p>Ubiquitin, a conserved protein, plays a central role in various fundamental cellular processes, contributing to the growth and pathogenicity of <italic>Cryptococcus</italic> species (<xref ref-type="bibr" rid="B43">Liu and Xue, 2011</xref>). Inositol catabolism was identified as having a role in capsule growth and contributing to the pathogenesis of CNS cryptococcosis. The presence of abundant inositol in human and animal brains, coupled with the advanced inositol acquisition system in the yeast <italic>Cryptococcus</italic>, indicates a potential link between host inositol utilization and the development of cryptococcal meningitis. A study demonstrates the significant role of inositol in facilitating <italic>Cryptococcus</italic> traversal across the blood-brain barrier in both <italic>in vitro</italic> human BBB models and <italic>in vivo</italic> animal models (<xref ref-type="bibr" rid="B44">Liu et&#xa0;al., 2013</xref>).</p>
<p>Gene expression related to cellular components, including actin cytoskeleton organization, F-actin capping protein complex, mitochondrial and nuclear remodeling, exhibited significant modulation during infection. These alterations likely influence the structural and functional adaptations of <italic>Cryptococcus</italic> within the host environment. The study also revealed the regulation of genes associated with stress responses, energy metabolism, and protein modification, indicating the pathogen's ability to adapt to the challenges posed by the host environment. Notably, genes involved in translation, DNA-templated transcription, and elongation were differentially regulated, suggesting potential adaptive mechanisms employed by <italic>Cryptococcus</italic> species during infection.</p>
</sec>
<sec id="s3_9">
<label>3.9</label>
<title>Substantial genomic variation at 4 h and 18 h post-infection</title>
<p>In our study, conducted with an aim at elucidating the intricate dynamics underlying host-pathogen interactions, we examined the expression profiles of the top-listed genes, differentially expressed at the 4<sup>th</sup> hour time point, exhibited consistent expression levels at the 18<sup>th</sup> hour time point in the infecting pathogen <italic>Cryptococcus</italic> species complex. Our findings revealed that key signaling pathways, known for their crucial roles in the immunopathogenesis of cryptococcal meningitis, exhibited a remarkable degree of consistency in their expression patterns at both the 4<sup>th</sup> and 18<sup>th</sup> hour time points within HBMECs, an <italic>in vitro</italic> cell culture system. This finding emphasizes that immune signaling pathways enriched in HBMECs i.e. the host cells under investigation, as well as virulence-related attributes that are differentially regulated in the pathogen, play pivotal roles throughout the early and later time points of infection process. These results underscore the significant contributions of these pathways and the associated genes in shaping the complex interplay between the host and the pathogen over the course of infection.</p>
</sec>
<sec id="s3_10">
<label>3.10</label>
<title>Comparative expression profiles of clinical vs. Environmental isolates</title>
<p>After investigating the virulence-related attributes exhibited by the pathogen and the immune responses displayed by the host during the critical events of infection under controlled <italic>in vitro</italic> experimental conditions, we proceeded to assess the relative competency of environmental isolates of cryptococci in infecting HBMECs. HBMECs constitute a significant component of the human blood-brain barrier and are integral to the establishment of central nervous system infections. We assessed the invasion capability and virulence potential of environmental strains of cryptococci in comparison to that of clinical isolates and concurrently examined alterations in the regulation of gene expression associated with virulence factors when infecting HBMECs <italic>in vitro</italic>.</p>
<p>Our findings demonstrated that the naive environmental isolates of cryptococci despite lacking prior exposure to the human host milieu, exhibited a comparable infectivity and virulence profile to that of clinical isolates when infecting HBMECs. This was supported by the observed expression of various virulence-related elements associated with melanization, polysaccharide capsule formation, metabolite and energy generation, apoptotic and autophagy related functions in clinical as well as environmental isolates of cryptococci which are essential for establishing and progressing infections. Furthermore, the gene expression related to the alterations in the cellular components, potentially influencing the structural and functional adaptive mechanisms employed by cryptococci within the host environment exhibited remarkable similarity between clinical and environmental isolates. Notably, both clinical and environmental isolates of <italic>Cryptococcus</italic> demonstrated comparable impacts on the host by inducing the activation of essential immune signalling pathways within the host during <italic>in vitro</italic> infection.</p>
</sec>
<sec id="s3_11">
<label>3.11</label>
<title>DEGs validation</title>
<p>To evaluate the correlation between dual RNA-seq and qPCR, nine genes were selected for validation&#x2014;seven from the host (HBMECs) and two from the pathogen (<italic>Cryptococcus</italic>). <xref ref-type="fig" rid="f8"><bold>Figure&#xa0;8</bold></xref> illustrates the comparison of Log2 fold change values obtained through both techniques. The correlation between the two methods was assessed using Pearson&#x2019;s correlation test. The gene expression results from RNA-seq exhibited a robust correlation (r = 0.8858, p-value = 0.00341) with the gene expression values obtained through qPCR. One pathogen target gene (CGB_A4480W) was excluded from the correlation analysis due to significant variation in Log2Foldchange values (12.66 and 3.09) obtained by RNA-seq and qPCR. No correlation was observed between RNA-seq and qPCR for the host target gene TRIB3, indicating a potential technical error in the experiment. However, upon comparing the remaining seven targets out of the overall nine, our findings suggest that sequencing yielded dependable outcomes, underscoring the accuracy and reproducibility of the techniques.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Bar plot depicting the correlation between Dual RNASeq and qPCR. The gene expression results from RNA-seq exhibited a robust correlation (r = 0.8858, p-value = 0.00341) with the gene expression values obtained through qPCR.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1735570-g008.tif">
<alt-text content-type="machine-generated">Bar graph comparing log2 fold changes in gene expression for different target genes using qPCR and RNASeq. FOS and FOSB show negative changes in RNASeq. DDIT4, VEGFA, TRIB3, and CGB_A4770W are positively expressed, with RNASeq values generally higher.</alt-text>
</graphic></fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>This study represents a comprehensive preliminary investigation into the early events of <italic>Cryptococcus</italic>&#x2013;host interaction, integrating ultrastructural and transcriptomic data to provide mechanistic insights into endothelial responses during fungal invasion. We demonstrated that both clinical and environmental isolates of the <italic>Cryptococcus neoformans/gattii</italic> species complex can invade HBMECs, inducing significant ultrastructural changes at both 4 and 18 hours post-infection. These alterations involved various subcellular organelles, reflecting the host's defense mechanisms and the pathogen's strategies for survival and propagation. One such response involves the formation of membrane rufflings, which are temporary protrusions of the cell membrane resulting from alterations in the actin cytoskeleton dynamics. It is an integral part of the host cell's response to the presence of the pathogen that facilitates pathogen adherence and internalization (<xref ref-type="bibr" rid="B13">Filler and Sheppard, 2006</xref>). In parallel, infected HBMECs exhibited extensive formation of microvilli which are finger-like projections on the surface area of endothelium that may enhance the cell's capacity to interact with the external environment, potentially augment pathogen detection and capture of cryptococcal cells (<xref ref-type="bibr" rid="B11">Eug&#xe8;ne et&#xa0;al., 2002</xref>).</p>
<p>The formation of autophagosome within the HBMECs is a strategic move in the host&#x2019;s battle against the pathogen. These specialized vesicles encapsulate potentially harmful damaged organelles and intracellular pathogens, thereby marking them for subsequent degradation functioning to eliminate the pathogen (<xref ref-type="bibr" rid="B62">Riebisch et&#xa0;al., 2021</xref>). Autophagy, a highly regulated process can modulate the host's immune response by influencing the presentation of pathogen-derived antigens, contributing to the activation of immune cells and the production of immune-signaling molecules like cytokines and chemokines (<xref ref-type="bibr" rid="B74">Xu and Eissa, 2010</xref>; <xref ref-type="bibr" rid="B32">Jiang et&#xa0;al., 2019</xref>). However, <italic>Cryptococcus</italic> has evolved sophisticated strategies to resist or evade autophagic capture and degradation, highlighting the ever-evolving arms race between host and pathogen in the realm of infection.</p>
<p>Mitochondria play essential roles in innate immune responses triggering the expression of pro-inflammatory cytokines through the NF-kB pathway and contribute to the generation of ROS as part of the cellular defense against pathogenic infections (<xref ref-type="bibr" rid="B20">Fu et&#xa0;al., 2022</xref>). The observed alterations could imply on impairment in the regulation of inflammatory response against the invading pathogen. Conversely, the observed mitochondrial alterations may represent a counter measure by the host cell in response to the infection, potentially aimed at limiting the replication and spread of <italic>Cryptococcus</italic> or initiating mitophagy (<xref ref-type="bibr" rid="B36">Khan et&#xa0;al., 2020</xref>) or apoptotic pathways as a defense mechanism.</p>
<p>Alterations in Golgi morphology may potentially disrupt the Golgi's ability to sort and modify proteins that could consequently impact the secretion of essential molecules involved in cellular signaling and immune responses and obstruct the post-translational modification in the host cell (<xref ref-type="bibr" rid="B42">Liu et&#xa0;al., 2021</xref>). Dysfunction of the Golgi apparatus has been documented in various infections caused by pathogens such as Orf virus (<xref ref-type="bibr" rid="B64">Rohde et&#xa0;al., 2012</xref>), Chlamydia trachomatis (<xref ref-type="bibr" rid="B30">Heuer et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B59">Pruneda et&#xa0;al., 2018</xref>), Hepatitis C virus (<xref ref-type="bibr" rid="B27">Hansen et&#xa0;al., 2017</xref>), Human Rhinovirus (<xref ref-type="bibr" rid="B49">Mousnier et&#xa0;al., 2014</xref>), and Rickettsia rickettsii (<xref ref-type="bibr" rid="B2">Aistleitner et&#xa0;al., 2020</xref>).</p>
<p>Morphological changes in the ER, suggest that cryptococcal infection can induce ER stress in HBMECs. When ER becomes stressed, it typically responds by dilating or expanding to cope with the increased accumulation of misfolded or misassembled proteins within the ER lumen. This ER dilation may be an indicator of cellular attempts to manage the stress induced by the infection possibly initiating the unfolded protein response (UPR), a cellular signaling pathway aimed at restoring ER homeostasis (<xref ref-type="bibr" rid="B16">Frabutt and Zheng, 2016</xref>; <xref ref-type="bibr" rid="B23">Glingston et&#xa0;al., 2019</xref>). The observed changes could be a manifestation of the UPR leading to immunomodulatory effects that influence the production of cytokines and other immune-related factors, potentially affecting the host's immune response to the infection (<xref ref-type="bibr" rid="B66">Smith, 2018</xref>).</p>
<p>The observed nuclear morphological changes in HBMECs likely signify stress responses triggered by cryptococcal infection. Such alterations can influence gene expression thereby affecting the regulation of specific genes associated with immune responses, inflammation and various other cellular processes in HBMECs. Disruption of the nuclear envelope, which is vital for nucleocytoplasmic transport suggests impaired cellular regulation under pathogenic stress. These changes may also impact immune signaling that could influence the activity of transcription factors and nuclear proteins affecting cytokine and chemokine production during infection (<xref ref-type="bibr" rid="B50">Nastasi et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B65">Selezneva et&#xa0;al., 2022</xref>). Cytoplasmic vacuolation could be a cellular response to infection and may serve as a containment strategy, aimed at sequestering, neutralizing, and ultimately degrading the invading fungal cells. However, it&#x2019;s important to note that <italic>Cryptococcus</italic> may also employ its own strategies to evade or circumvent these host defenses in its quest for persistence. The stress fibers assist in facilitating the movement of pathogen containing vesicles within the cell, potentially directing them toward lysosomes for degradation aiding in efficient engulfment of the pathogen (<xref ref-type="bibr" rid="B17">Franco and Shuman, 2012</xref>).</p>
<p>Dual RNA-Seq profiling revealed a dynamic transcriptional interplay between <italic>Cryptococcus</italic> spp. and HBMECs during <italic>in vitro</italic> infection. Host cells exhibited differential regulation of key immune pathways including PI3K-Akt, JAK-STAT, MAPK, NF-&#x3ba;B, and IL-17 signaling, reflecting a tightly controlled inflammatory response to maintain BBB integrity while combating the fungal invasion. Notably, immediate early genes such as <italic>FOS</italic>, <italic>JUN</italic>, and <italic>EGR1</italic> were prominently expressed, suggesting rapid transcriptional activation. Simultaneously, genes linked to autophagy, ferroptosis, and cytokine signaling were modulated, indicating a multilayered defense strategy. On the pathogen side, clinical and environmental isolates showed similar expression of virulence-related genes, including those involved in melanin production, capsule biosynthesis, and stress response. These findings highlight a conserved host response to cryptococcal infection and reveal that environmental strains possess comparable pathogenic potential. The study underscores the significance of early immune signaling events at the BBB and provides a foundation for identifying molecular targets for antifungal intervention.</p>
<p>Further reinforcing our transcriptomic findings, ultrastructural observations obtained via TEM revealed hallmark cellular alterations in infected HBMECs. Notably, the subcellular changes observed through TEM correspond with the differential expression of host genes associated with cellular components, as identified through RNA-Seq. This concordance between structural and transcriptomic evidence provides mutual validation, strengthening the reliability of our findings and underscoring the biological relevance of the host-pathogen interactions characterized in this study. These findings suggest that endothelial cells of the BBB deploy comparable defense mechanisms against <italic>Cryptococcus</italic>, irrespective of whether the invading isolate is of clinical or environmental origin. Significantly, both isolate types demonstrated equivalent invasive capacity and induced comparable morphological adaptations in HBMECs, underscoring their shared pathogenic potential. Taken together, this integrative study provides novel insight into the early host-pathogen dynamics at the BBB. The dual application of TEM and dual RNA-Seq in tandem provides a robust framework for dissecting host-fungal interactions and lays the groundwork for future functional and translational studies targeting improved therapeutic strategies for cryptococcal meningitis.</p>
<p>However, it is essential to acknowledge that <italic>in vitro</italic> cell culture experiments have inherent limitations compared to <italic>in vivo</italic> conditions, as they do not fully replicate the complexity of host-pathogen interactions within a living organism when studying complex biological processes like the BBB. Additionally, functional validation of identified differentially expressed genes and pathways was beyond the current scope of the study. Enhanced recovery of pathogen-derived reads aligning to the custom-built cryptococcal reference genome within the co-culture libraries could have substantially improved the depth and accuracy of the pathogen's differential gene expression analysis.</p>
<p>Future studies can address these limitations by adopting an <italic>in vitro</italic> 3D model of the blood-brain barrier and optimizing the sequencing of pathogen-derived reads. These advancements would complement our current findings and provide supplementary insights. In addition studies on microRNA can significantly contribute to our findings by unraveling additional layers of the host-pathogen interaction dynamics. Examining microRNA expression profiles in response to <italic>Cryptococcus</italic> invasion could elucidate the regulatory mechanisms governing the host's immune responses and help identify novel therapeutic targets or diagnostic biomarkers for cryptococcal meningitis.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <uri xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</uri>, PRJNA1068840.</p></sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>This study protocol was approved by Institute Ethics Committee, NIMHANS, under the approval number: NIMH/DO/15th Ethics sub-committee meeting/2021 dated 13-05-2021 and Institutional Bio-safety Committee under the approval number: NIMHANS/DO/IBSC meeting/2021 dated 30-03-2021. Informed consent was obtained from all human participants, ensuring their understanding of the study's objectives and their right to withdraw.</p></sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>PK: Supervision, Investigation, Software, Conceptualization, Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Formal analysis, Visualization, Methodology, Data curation, Validation. GU: Conceptualization, Supervision, Writing &#x2013; review &amp; editing, Investigation, Resources, Funding acquisition. RS: Supervision, Writing &#x2013; review &amp; editing, Methodology, Investigation. MV: Writing &#x2013; review &amp; editing, Funding acquisition, Investigation, Supervision, Resources. VK: Writing &#x2013; review &amp; editing, Investigation, Supervision. N: Investigation, Writing &#x2013; review &amp; editing, Supervision. NS: Conceptualization, Supervision, Funding acquisition, Resources, Writing &#x2013; review &amp; editing.</p></sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aaghaz</surname> <given-names>S.</given-names></name>
<name><surname>Sharma</surname> <given-names>K.</given-names></name>
<name><surname>Maurya</surname> <given-names>I. K.</given-names></name>
<name><surname>Rudramurthy</surname> <given-names>S. M.</given-names></name>
<name><surname>Singh</surname> <given-names>S.</given-names></name>
<name><surname>Kumar</surname> <given-names>V.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Anticryptococcal activity and mechanistic investigation of histidine-rich short peptides</article-title>. <source>J. Mol. Struct.</source> <volume>1276</volume>, <elocation-id>134813</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molstruc.2022.134813</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aistleitner</surname> <given-names>K.</given-names></name>
<name><surname>Clark</surname> <given-names>T.</given-names></name>
<name><surname>Dooley</surname> <given-names>C.</given-names></name>
<name><surname>Hackstadt</surname> <given-names>T.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Selective fragmentation of the trans-Golgi apparatus by Rickettsia rickettsii</article-title>. <source>PloS Pathogens.</source> <volume>16</volume>, <elocation-id>e1008582</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1008582</pub-id>, PMID: <pub-id pub-id-type="pmid">32421751</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Akins</surname> <given-names>P. T.</given-names></name>
<name><surname>Liu</surname> <given-names>P. K.</given-names></name>
<name><surname>Hsu</surname> <given-names>C. Y.</given-names></name>
</person-group> (<year>1996</year>). 
<article-title>Immediate early gene expression in response to cerebral ischemia: friend or foe</article-title>? <source>Stroke</source> <volume>27</volume>, <fpage>1682</fpage>&#x2013;<lpage>1687</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/01.STR.27.9.1682</pub-id>, PMID: <pub-id pub-id-type="pmid">8784149</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cao</surname> <given-names>C.</given-names></name>
<name><surname>Xue</surname> <given-names>C.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>More than just cleaning: ubiquitin-mediated proteolysis in fungal pathogenesis</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>11</volume>, <elocation-id>774613</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.774613</pub-id>, PMID: <pub-id pub-id-type="pmid">34858882</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Casadevall</surname> <given-names>A.</given-names></name>
<name><surname>Coelho</surname> <given-names>C.</given-names></name>
<name><surname>Alanio</surname> <given-names>A.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Mechanisms of <italic>Cryptococcus</italic> neoformans-mediated host damage</article-title>. <source>Front. Immunol.</source> <volume>9</volume>, <elocation-id>855</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.00855</pub-id>, PMID: <pub-id pub-id-type="pmid">29760698</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>S. H.</given-names></name>
<name><surname>Stins</surname> <given-names>M. F.</given-names></name>
<name><surname>Huang</surname> <given-names>S.-H.</given-names></name>
<name><surname>Chen</surname> <given-names>Y. H.</given-names></name>
<name><surname>Kwon-Chung</surname> <given-names>K.</given-names></name>
<name><surname>Chang</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2003</year>). 
<article-title><italic>Cryptococcus</italic> neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells</article-title>. <source>J. Med. Microbiol.</source> <volume>52</volume>, <fpage>961</fpage>&#x2013;<lpage>970</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/jmm.0.05230-0</pub-id>, PMID: <pub-id pub-id-type="pmid">14532340</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>Y. H.</given-names></name>
<name><surname>Chen</surname> <given-names>S. H. M.</given-names></name>
<name><surname>Jong</surname> <given-names>A.</given-names></name>
<name><surname>Zhou</surname> <given-names>Z. Y.</given-names></name>
<name><surname>Li</surname> <given-names>W.</given-names></name>
<name><surname>Suzuki</surname> <given-names>K.</given-names></name>
<etal/>
</person-group>. (<year>2002</year>). 
<article-title>Enhanced Escherichia coli invasion of human brain microvascular endothelial cells is associated with alterations in cytoskeleton induced by nicotine</article-title>. <source>Cell. Microbiol.</source> <volume>4</volume>, <fpage>503</fpage>&#x2013;<lpage>514</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1462-5822.2002.00209.x</pub-id>, PMID: <pub-id pub-id-type="pmid">12174085</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cicchese</surname> <given-names>J. M.</given-names></name>
<name><surname>Evans</surname> <given-names>S.</given-names></name>
<name><surname>Hult</surname> <given-names>C.</given-names></name>
<name><surname>Joslyn</surname> <given-names>L. R.</given-names></name>
<name><surname>Wessler</surname> <given-names>T.</given-names></name>
<name><surname>Millar</surname> <given-names>J. A.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>Dynamic balance of pro-and anti-inflammatory signals controls disease and limits pathology</article-title>. <source>Immunol. Rev.</source> <volume>285</volume>, <fpage>147</fpage>&#x2013;<lpage>167</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12671</pub-id>, PMID: <pub-id pub-id-type="pmid">30129209</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Conti</surname> <given-names>H. R.</given-names></name>
<name><surname>Gaffen</surname> <given-names>S. L.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>IL-17&#x2013;Mediated immunity to the opportunistic fungal pathogen Candida albicans</article-title>. <source>J. Immunol.</source> <volume>195</volume>, <fpage>780</fpage>&#x2013;<lpage>788</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1500909</pub-id>, PMID: <pub-id pub-id-type="pmid">26188072</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Diniz-Lima</surname> <given-names>I.</given-names></name>
<name><surname>Fonseca</surname> <given-names>L. M. D.</given-names></name>
<name><surname>Silva-Junior</surname> <given-names>E. B. D.</given-names></name>
<name><surname>Guimar&#xe3;es-de-Oliveira</surname> <given-names>J. C.</given-names></name>
<name><surname>Freire-de-Lima</surname> <given-names>L.</given-names></name>
<name><surname>Nascimento</surname> <given-names>D. O.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title><italic>Cryptococcus</italic>: history, epidemiology and immune evasion</article-title>. <source>Appl. Sci.</source> <volume>12</volume>, <fpage>7086</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/app12147086</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Eug&#xe8;ne</surname> <given-names>E.</given-names></name>
<name><surname>Hoffmann</surname> <given-names>I.</given-names></name>
<name><surname>Pujol</surname> <given-names>C.</given-names></name>
<name><surname>Couraud</surname> <given-names>P.-O.</given-names></name>
<name><surname>Bourdoulous</surname> <given-names>S.</given-names></name>
<name><surname>Nassif</surname> <given-names>X.</given-names></name>
</person-group> (<year>2002</year>). 
<article-title>Microvilli-like structures are associated with the internalization of virulent capsulated Neisseria meningitidis into vascular endothelial cells</article-title>. <source>J. Cell science.</source> <volume>115</volume>, <fpage>1231</fpage>&#x2013;<lpage>1241</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.115.6.1231</pub-id>, PMID: <pub-id pub-id-type="pmid">11884522</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Eugenin</surname> <given-names>E. A.</given-names></name>
<name><surname>Greco</surname> <given-names>J. M.</given-names></name>
<name><surname>Frases</surname> <given-names>S.</given-names></name>
<name><surname>Nosanchuk</surname> <given-names>J. D.</given-names></name>
<name><surname>Martinez</surname> <given-names>L. R.</given-names></name>
</person-group> (<year>2013</year>). 
<article-title>Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic <italic>Cryptococcus</italic> neoformans</article-title>. <source>J. Infect. diseases.</source> <volume>208</volume>, <fpage>699</fpage>&#x2013;<lpage>704</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jit117</pub-id>, PMID: <pub-id pub-id-type="pmid">23532099</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Filler</surname> <given-names>S. G.</given-names></name>
<name><surname>Sheppard</surname> <given-names>D. C.</given-names></name>
</person-group> (<year>2006</year>). 
<article-title>Fungal invasion of normally non-phagocytic host cells</article-title>. <source>PloS pathogens.</source> <volume>2</volume>, <elocation-id>e129</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.0020129</pub-id>, PMID: <pub-id pub-id-type="pmid">17196036</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Florio</surname> <given-names>A. R.</given-names></name>
<name><surname>Ferrari</surname> <given-names>S.</given-names></name>
<name><surname>De Carolis</surname> <given-names>E.</given-names></name>
<name><surname>Torelli</surname> <given-names>R.</given-names></name>
<name><surname>Fadda</surname> <given-names>G.</given-names></name>
<name><surname>Sanguinetti</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). 
<article-title>Genome-wide expression profiling of the response to short-term exposure to fluconazole in <italic>Cryptococcus</italic> neoformans serotype A</article-title>. <source>BMC Microbiol.</source> <volume>11</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2180-11-97</pub-id>, PMID: <pub-id pub-id-type="pmid">21569340</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fortwendel</surname> <given-names>J. R.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Ras-mediated signal transduction and virulence in human pathogenic fungi</article-title>. <source>Fungal Genomics Biol.</source> <volume>2</volume>, <fpage>105</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4172/2165-8056.1000105</pub-id>, PMID: <pub-id pub-id-type="pmid">24855584</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Frabutt</surname> <given-names>D. A.</given-names></name>
<name><surname>Zheng</surname> <given-names>Y.-H.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Arms race between enveloped viruses and the host ERAD machinery</article-title>. <source>Viruses.</source> <volume>8</volume>, <fpage>255</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/v8090255</pub-id>, PMID: <pub-id pub-id-type="pmid">27657106</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Franco</surname> <given-names>I. S.</given-names></name>
<name><surname>Shuman</surname> <given-names>H. A.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>A pathogen&#x2019;s journey in the host cell: Bridges between actin and traffic</article-title>. <source>Bioarchitecture.</source> <volume>2</volume>, <fpage>38</fpage>&#x2013;<lpage>42</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/bioa.20422</pub-id>, PMID: <pub-id pub-id-type="pmid">22754628</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Freitas</surname> <given-names>G. J.</given-names></name>
<name><surname>Gouveia-Eufrasio</surname> <given-names>L.</given-names></name>
<name><surname>Emidio</surname> <given-names>E. C.</given-names></name>
<name><surname>Carneiro</surname> <given-names>H. C.</given-names></name>
<name><surname>de Matos Baltazar</surname> <given-names>L.</given-names></name>
<name><surname>Costa</surname> <given-names>M. C.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>The dynamics of <italic>Cryptococcus</italic> neoformans cell and transcriptional remodeling during infection</article-title>. <source>Cells.</source> <volume>11</volume>, <fpage>3896</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells11233896</pub-id>, PMID: <pub-id pub-id-type="pmid">36497155</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Friedrich</surname> <given-names>D.</given-names></name>
<name><surname>Fecher</surname> <given-names>R. A.</given-names></name>
<name><surname>Rupp</surname> <given-names>J.</given-names></name>
<name><surname>Deepe</surname> <given-names>G. S.</given-names> <suffix>Jr.</suffix></name>
</person-group> (<year>2017</year>). 
<article-title>Impact of HIF-1&#x3b1; and hypoxia on fungal growth characteristics and fungal immunity</article-title>. <source>Microbes infection.</source> <volume>19</volume>, <fpage>204</fpage>&#x2013;<lpage>209</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micinf.2016.10.008</pub-id>, PMID: <pub-id pub-id-type="pmid">27810563</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fu</surname> <given-names>C.</given-names></name>
<name><surname>Cao</surname> <given-names>N.</given-names></name>
<name><surname>Liu</surname> <given-names>W.</given-names></name>
<name><surname>Zhang</surname> <given-names>Z.</given-names></name>
<name><surname>Yang</surname> <given-names>Z.</given-names></name>
<name><surname>Zhu</surname> <given-names>W.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Crosstalk between mitophagy and innate immunity in viral infection</article-title>. <source>Front. Microbiol.</source> <volume>13</volume>, <elocation-id>1064045</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2022.1064045</pub-id>, PMID: <pub-id pub-id-type="pmid">36590405</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gal&#xe1;n</surname> <given-names>J. E.</given-names></name>
<name><surname>Zhou</surname> <given-names>D.</given-names></name>
</person-group> (<year>2000</year>). 
<article-title>Striking a balance: modulation of the actin cytoskeleton by Salmonella</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>97</volume>, <fpage>8754</fpage>&#x2013;<lpage>8761</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.97.16.8754</pub-id>, PMID: <pub-id pub-id-type="pmid">10922031</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gius</surname> <given-names>D.</given-names></name>
<name><surname>Cao</surname> <given-names>X.</given-names></name>
<name><surname>Rauscher</surname> <given-names>F.</given-names> <suffix>3rd</suffix></name>
<name><surname>Cohen</surname> <given-names>D. R.</given-names></name>
<name><surname>Curran</surname> <given-names>T.</given-names></name>
<name><surname>Sukhatme</surname> <given-names>V. P.</given-names></name>
</person-group> (<year>1990</year>). 
<article-title>Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements</article-title>. <source>Mol. Cell. Biol</source>. <volume>10</volume>, <page-range>4243&#x2013;4255</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mcb.10.8.4243-4255.1990</pub-id>, PMID: <pub-id pub-id-type="pmid">2115122</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Glingston</surname> <given-names>R. S.</given-names></name>
<name><surname>Deb</surname> <given-names>R.</given-names></name>
<name><surname>Kumar</surname> <given-names>S.</given-names></name>
<name><surname>Nagotu</surname> <given-names>S.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Organelle dynamics and viral infections: At cross roads</article-title>. <source>Microbes Infection.</source> <volume>21</volume>, <fpage>20</fpage>&#x2013;<lpage>32</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micinf.2018.06.002</pub-id>, PMID: <pub-id pub-id-type="pmid">29953921</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gourlay</surname> <given-names>C. W.</given-names></name>
<name><surname>Ayscough</surname> <given-names>K. R.</given-names></name>
</person-group> (<year>2005</year>). 
<article-title>Identification of an upstream regulatory pathway controlling actin-mediated apoptosis in yeast</article-title>. <source>J. Cell science.</source> <volume>118</volume>, <fpage>2119</fpage>&#x2013;<lpage>2132</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.02337</pub-id>, PMID: <pub-id pub-id-type="pmid">15855235</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gourlay</surname> <given-names>C. W.</given-names></name>
<name><surname>Ayscough</surname> <given-names>K. R.</given-names></name>
</person-group> (<year>2006</year>). 
<article-title>Actin-induced hyperactivation of the Ras signaling pathway leads to apoptosis in Saccharomyces cerevisiae</article-title>. <source>Mol. Cell. Biol.</source> <volume>26</volume>, <fpage>6487</fpage>&#x2013;<lpage>6501</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MCB.00117-06</pub-id>, PMID: <pub-id pub-id-type="pmid">16914733</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Guo</surname> <given-names>X.</given-names></name>
<name><surname>Mao</surname> <given-names>X.</given-names></name>
<name><surname>Tian</surname> <given-names>D.</given-names></name>
<name><surname>Liao</surname> <given-names>Y.</given-names></name>
<name><surname>Su</surname> <given-names>B.</given-names></name>
<name><surname>Ye</surname> <given-names>C.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title><italic>Cryptococcus</italic> neoformans infection induces IL-17 production by promoting STAT3 phosphorylation in CD4+ T cells</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <elocation-id>872286</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.872286</pub-id>, PMID: <pub-id pub-id-type="pmid">35720334</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hansen</surname> <given-names>M. D.</given-names></name>
<name><surname>Johnsen</surname> <given-names>I. B.</given-names></name>
<name><surname>Stiberg</surname> <given-names>K. A.</given-names></name>
<name><surname>Sherstova</surname> <given-names>T.</given-names></name>
<name><surname>Wakita</surname> <given-names>T.</given-names></name>
<name><surname>Richard</surname> <given-names>G. M.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>114</volume>, <fpage>E3462</fpage>&#x2013;<lpage>E3E71</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1616683114</pub-id>, PMID: <pub-id pub-id-type="pmid">28389568</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hayward</surname> <given-names>R. J.</given-names></name>
<name><surname>Humphrys</surname> <given-names>M. S.</given-names></name>
<name><surname>Huston</surname> <given-names>W. M.</given-names></name>
<name><surname>Myers</surname> <given-names>G. S.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Dual RNA-seq analysis of <italic>in vitro</italic> infection multiplicity and RNA depletion methods in Chlamydia-infected epithelial cells</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <elocation-id>10399</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-89921-x</pub-id>, PMID: <pub-id pub-id-type="pmid">34001998</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Helmerhorst</surname> <given-names>E. J.</given-names></name>
<name><surname>Troxler</surname> <given-names>R. F.</given-names></name>
<name><surname>Oppenheim</surname> <given-names>F. G.</given-names></name>
</person-group> (<year>2001</year>). 
<article-title>The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>98</volume>, <fpage>14637</fpage>&#x2013;<lpage>14642</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.141366998</pub-id>, PMID: <pub-id pub-id-type="pmid">11717389</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Heuer</surname> <given-names>D.</given-names></name>
<name><surname>Lipinski</surname> <given-names>A. R.</given-names></name>
<name><surname>Machuy</surname> <given-names>N.</given-names></name>
<name><surname>Karlas</surname> <given-names>A.</given-names></name>
<name><surname>Wehrens</surname> <given-names>A.</given-names></name>
<name><surname>Siedler</surname> <given-names>F.</given-names></name>
<etal/>
</person-group>. (<year>2009</year>). 
<article-title>Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction</article-title>. <source>Nature.</source> <volume>457</volume>, <fpage>731</fpage>&#x2013;<lpage>735</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature07578</pub-id>, PMID: <pub-id pub-id-type="pmid">19060882</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jiang</surname> <given-names>S.-T.</given-names></name>
<name><surname>Chang</surname> <given-names>A.-N.</given-names></name>
<name><surname>Han</surname> <given-names>L.-T.</given-names></name>
<name><surname>Guo</surname> <given-names>J.-S.</given-names></name>
<name><surname>Li</surname> <given-names>Y.-H.</given-names></name>
<name><surname>Liu</surname> <given-names>T.-B.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Autophagy regulates fungal virulence and sexual reproduction in <italic>Cryptococcus</italic> neoformans</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>8</volume>, <elocation-id>374</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2020.00374</pub-id>, PMID: <pub-id pub-id-type="pmid">32528953</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jiang</surname> <given-names>G.-M.</given-names></name>
<name><surname>Tan</surname> <given-names>Y.</given-names></name>
<name><surname>Wang</surname> <given-names>H.</given-names></name>
<name><surname>Peng</surname> <given-names>L.</given-names></name>
<name><surname>Chen</surname> <given-names>H.-T.</given-names></name>
<name><surname>Meng</surname> <given-names>X.-J.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>The relationship between autophagy and the immune system and its applications for tumor immunotherapy</article-title>. <source>Mol. cancer.</source> <volume>18</volume>, <fpage>1</fpage>&#x2013;<lpage>22</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12943-019-0944-z</pub-id>, PMID: <pub-id pub-id-type="pmid">30678689</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jong</surname> <given-names>A.</given-names></name>
<name><surname>Wu</surname> <given-names>C. H.</given-names></name>
<name><surname>Zhou</surname> <given-names>W.</given-names></name>
<name><surname>Chen</surname> <given-names>H. M.</given-names></name>
<name><surname>Huang</surname> <given-names>S. H.</given-names></name>
</person-group> (<year>2008</year>). 
<article-title>Infectomic analysis of gene expression profiles of human brain microvascular endothelial cells infected with <italic>Cryptococcus</italic> neoformans</article-title>. <source>J. BioMed. Biotechnol.</source> <volume>2008</volume>, <elocation-id>375620</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2008/375620</pub-id>, PMID: <pub-id pub-id-type="pmid">18309373</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kacprzyk</surname> <given-names>L.</given-names></name>
<name><surname>Rydeng&#xe5;rd</surname> <given-names>V.</given-names></name>
<name><surname>M&#xf6;rgelin</surname> <given-names>M.</given-names></name>
<name><surname>Davoudi</surname> <given-names>M.</given-names></name>
<name><surname>Pasupuleti</surname> <given-names>M.</given-names></name>
<name><surname>Malmsten</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). 
<article-title>Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions</article-title>. <source>Biochim. Biophys. Acta (BBA)-Biomembranes.</source> <volume>1768</volume>, <fpage>2667</fpage>&#x2013;<lpage>2680</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbamem.2007.06.020</pub-id>, PMID: <pub-id pub-id-type="pmid">17655823</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kadry</surname> <given-names>H.</given-names></name>
<name><surname>Noorani</surname> <given-names>B.</given-names></name>
<name><surname>Cucullo</surname> <given-names>L.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>A blood&#x2013;brain barrier overview on structure, function, impairment, and biomarkers of integrity</article-title>. <source>Fluids Barriers CNS.</source> <volume>17</volume>, <fpage>1</fpage>&#x2013;<lpage>24</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12987-020-00230-3</pub-id>, PMID: <pub-id pub-id-type="pmid">33208141</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Khan</surname> <given-names>S.</given-names></name>
<name><surname>Raj</surname> <given-names>D.</given-names></name>
<name><surname>Jaiswal</surname> <given-names>K.</given-names></name>
<name><surname>Lahiri</surname> <given-names>A.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Modulation of host mitochondrial dynamics during bacterial infection</article-title>. <source>Mitochondrion.</source> <volume>53</volume>, <fpage>140</fpage>&#x2013;<lpage>149</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mito.2020.05.005</pub-id>, PMID: <pub-id pub-id-type="pmid">32470613</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>King</surname> <given-names>J. S.</given-names></name>
<name><surname>Gueho</surname> <given-names>A.</given-names></name>
<name><surname>Hagedorn</surname> <given-names>M.</given-names></name>
<name><surname>Gopaldass</surname> <given-names>N.</given-names></name>
<name><surname>Leuba</surname> <given-names>F.</given-names></name>
<name><surname>Soldati</surname> <given-names>T.</given-names></name>
<etal/>
</person-group>. (<year>2013</year>). 
<article-title>WASH is required for lysosomal recycling and efficient autophagic and phagocytic digestion</article-title>. <source>Mol. Biol. Cell.</source> <volume>24</volume>, <fpage>2714</fpage>&#x2013;<lpage>2726</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1091/mbc.e13-02-0092</pub-id>, PMID: <pub-id pub-id-type="pmid">23885127</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kozubowski</surname> <given-names>L.</given-names></name>
<name><surname>Lee</surname> <given-names>S. C.</given-names></name>
<name><surname>Heitman</surname> <given-names>J.</given-names></name>
</person-group> (<year>2009</year>). 
<article-title>Signalling pathways in the pathogenesis of Cryptococcus</article-title>. <source>Cell. Microbiol.</source> <volume>11</volume>, <fpage>370</fpage>&#x2013;<lpage>380</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-5822.2008.01273.x</pub-id>, PMID: <pub-id pub-id-type="pmid">19170685</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kronstad</surname> <given-names>J.</given-names></name>
<name><surname>Saikia</surname> <given-names>S.</given-names></name>
<name><surname>Nielson</surname> <given-names>E. D.</given-names></name>
<name><surname>Kretschmer</surname> <given-names>M.</given-names></name>
<name><surname>Jung</surname> <given-names>W.</given-names></name>
<name><surname>Hu</surname> <given-names>G.</given-names></name>
<etal/>
</person-group>. (<year>2012</year>). 
<article-title>Adaptation of <italic>Cryptococcus</italic> neoformans to mammalian hosts: integrated regulation of metabolism and virulence</article-title>. <source>Eukaryot Cell.</source> <volume>11</volume>, <fpage>109</fpage>&#x2013;<lpage>118</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/EC.05273-11</pub-id>, PMID: <pub-id pub-id-type="pmid">22140231</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lahiri</surname> <given-names>S.</given-names></name>
<name><surname>Banerjee</surname> <given-names>A.</given-names></name>
<name><surname>Bhutda</surname> <given-names>S.</given-names></name>
<name><surname>Palaniappan</surname> <given-names>M.</given-names></name>
<name><surname>Bahubali</surname> <given-names>V.</given-names></name>
<name><surname>Manjunath</surname> <given-names>N.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title><italic>In vitro</italic> expression of vital virulent genes of clinical and environmental isolates of <italic>Cryptococcus</italic> neoformans/gattii in endothelial cells of human blood-brain barrier</article-title>. <source>J. Mycologie Medicale.</source> <volume>29</volume>, <fpage>239</fpage>&#x2013;<lpage>244</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mycmed.2019.06.001</pub-id>, PMID: <pub-id pub-id-type="pmid">31221506</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Leadsham</surname> <given-names>J. E.</given-names></name>
<name><surname>Miller</surname> <given-names>K.</given-names></name>
<name><surname>Ayscough</surname> <given-names>K. R.</given-names></name>
<name><surname>Colombo</surname> <given-names>S.</given-names></name>
<name><surname>Martegani</surname> <given-names>E.</given-names></name>
<name><surname>Sudbery</surname> <given-names>P.</given-names></name>
<etal/>
</person-group>. (<year>2009</year>). 
<article-title>Whi2p links nutritional sensing to actin-dependent Ras-cAMP-PKA regulation and apoptosis in yeast</article-title>. <source>J. Cell science.</source> <volume>122</volume>, <fpage>706</fpage>&#x2013;<lpage>715</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.042424</pub-id>, PMID: <pub-id pub-id-type="pmid">19208759</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>J.</given-names></name>
<name><surname>Huang</surname> <given-names>Y.</given-names></name>
<name><surname>Li</surname> <given-names>T.</given-names></name>
<name><surname>Jiang</surname> <given-names>Z.</given-names></name>
<name><surname>Zeng</surname> <given-names>L.</given-names></name>
<name><surname>Hu</surname> <given-names>Z.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>The role of the Golgi apparatus in disease</article-title>. <source>Int. J. Mol. Med.</source> <volume>47</volume>, <fpage>1</fpage>.
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>T.-B.</given-names></name>
<name><surname>Xue</surname> <given-names>C.</given-names></name>
</person-group> (<year>2011</year>). 
<article-title>The ubiquitin-proteasome system and F-box proteins in pathogenic fungi</article-title>. <source>Mycobiology.</source> <volume>39</volume>, <fpage>243</fpage>&#x2013;<lpage>248</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5941/MYCO.2011.39.4.243</pub-id>, PMID: <pub-id pub-id-type="pmid">22783111</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>T.-B.</given-names></name>
<name><surname>Kim</surname> <given-names>J.-C.</given-names></name>
<name><surname>Wang</surname> <given-names>Y.</given-names></name>
<name><surname>Toffaletti</surname> <given-names>D. L.</given-names></name>
<name><surname>Eugenin</surname> <given-names>E.</given-names></name>
<name><surname>Perfect</surname> <given-names>J. R.</given-names></name>
<etal/>
</person-group>. (<year>2013</year>). 
<article-title>Brain inositol is a novel stimulator for promoting <italic>Cryptococcus</italic> penetration of the blood-brain barrier</article-title>. <source>PloS pathogens.</source> <volume>9</volume>, <elocation-id>e1003247</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1003247</pub-id>, PMID: <pub-id pub-id-type="pmid">23592982</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>S.</given-names></name>
<name><surname>Youngchim</surname> <given-names>S.</given-names></name>
<name><surname>Zamith-Miranda</surname> <given-names>D.</given-names></name>
<name><surname>Nosanchuk</surname> <given-names>J. D.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Fungal melanin and the mammalian immune system</article-title>. <source>J. Fungi.</source> <volume>7</volume>, <fpage>264</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/jof7040264</pub-id>, PMID: <pub-id pub-id-type="pmid">33807336</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>L&#xf3;pez-Agudelo</surname> <given-names>V. A.</given-names></name>
<name><surname>Baena</surname> <given-names>A.</given-names></name>
<name><surname>Barrera</surname> <given-names>V.</given-names></name>
<name><surname>Cabarcas</surname> <given-names>F.</given-names></name>
<name><surname>Alzate</surname> <given-names>J. F.</given-names></name>
<name><surname>Beste</surname> <given-names>D. J.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Dual RNA sequencing of Mycobacterium tuberculosis-infected human splenic macrophages reveals a strain-dependent host&#x2013;pathogen response to infection</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>, <fpage>1803</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23031803</pub-id>, PMID: <pub-id pub-id-type="pmid">35163725</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>May</surname> <given-names>R. C.</given-names></name>
<name><surname>Stone</surname> <given-names>N. R.</given-names></name>
<name><surname>Wiesner</surname> <given-names>D. L.</given-names></name>
<name><surname>Bicanic</surname> <given-names>T.</given-names></name>
<name><surname>Nielsen</surname> <given-names>K.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title><italic>Cryptococcus</italic>: from environmental saprophyte to global pathogen</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>14</volume>, <fpage>106</fpage>&#x2013;<lpage>117</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro.2015.6</pub-id>, PMID: <pub-id pub-id-type="pmid">26685750</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Maziarz</surname> <given-names>E. K.</given-names></name>
<name><surname>Perfect</surname> <given-names>J. R.</given-names></name>
</person-group> (<year>2015</year>). &#x201c;
<article-title>Cryptococcosis</article-title>,&#x201d; in <source>Diagnosis and treatment of fungal infections</source> (
<publisher-name>Cham, Switzerland</publisher-name>: <publisher-loc>Springer</publisher-loc>), <fpage>175</fpage>&#x2013;<lpage>193</lpage>.
</mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mousnier</surname> <given-names>A.</given-names></name>
<name><surname>Swieboda</surname> <given-names>D.</given-names></name>
<name><surname>Pinto</surname> <given-names>A.</given-names></name>
<name><surname>Gued&#xe1;n</surname> <given-names>A.</given-names></name>
<name><surname>Rogers</surname> <given-names>A. V.</given-names></name>
<name><surname>Walton</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>2014</year>). 
<article-title>Human rhinovirus 16 causes Golgi apparatus fragmentation without blocking protein secretion</article-title>. <source>J. Virology.</source> <volume>88</volume>, <fpage>11671</fpage>&#x2013;<lpage>11685</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.01170-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25100828</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nastasi</surname> <given-names>C.</given-names></name>
<name><surname>Mannarino</surname> <given-names>L.</given-names></name>
<name><surname>D&#x2019;Incalci</surname> <given-names>M.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>DNA damage response and immune defense</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume>, <fpage>7504</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21207504</pub-id>, PMID: <pub-id pub-id-type="pmid">33053746</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Negroni</surname> <given-names>R.</given-names></name>
<name><surname>Arechavala</surname> <given-names>A. I.</given-names></name>
</person-group> (<year>2015</year>). &#x201c;
<article-title>Pathogenesis of cryptococcosis in humans</article-title>,&#x201d; in <source>Human emerging and re-emerging infections: viral and parasitic infections</source> (<publisher-loc>Hoboken, New Jersey, USA</publisher-loc>: 
<publisher-name>Wiley Online Library, John Wiley &amp; Sons</publisher-name>), <fpage>915</fpage>&#x2013;<lpage>927</lpage>.
</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nweze</surname> <given-names>E. I.</given-names></name>
<name><surname>Kechia</surname> <given-names>F. A.</given-names></name>
<name><surname>Dibua</surname> <given-names>U. E.</given-names></name>
<name><surname>Eze</surname> <given-names>C.</given-names></name>
<name><surname>Onoja</surname> <given-names>U. S.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>Isolation of <italic>Cryptococcus</italic> neoformans from environmental samples collected in Southeastern Nigeria</article-title>. <source>Rev. Inst Med. Trop. Sao Paulo.</source> <volume>57</volume>, <fpage>295</fpage>&#x2013;<lpage>298</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/S0036-46652015000400004</pub-id>, PMID: <pub-id pub-id-type="pmid">26422152</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ozaki</surname> <given-names>T.</given-names></name>
<name><surname>Nakagawara</surname> <given-names>A.</given-names></name>
</person-group> (<year>2011</year>). 
<article-title>Role of p53 in cell death and human cancers</article-title>. <source>Cancers.</source> <volume>3</volume>, <fpage>994</fpage>&#x2013;<lpage>1013</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers3010994</pub-id>, PMID: <pub-id pub-id-type="pmid">24212651</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pentland</surname> <given-names>D. R.</given-names></name>
<name><surname>Piper-Brown</surname> <given-names>E.</given-names></name>
<name><surname>M&#xfc;hlschlegel</surname> <given-names>F. A.</given-names></name>
<name><surname>Gourlay</surname> <given-names>C. W.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Ras signalling in pathogenic yeasts</article-title>. <source>Microbial Cell.</source> <volume>5</volume>, <fpage>63</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.15698/mic2018.02.612</pub-id>, PMID: <pub-id pub-id-type="pmid">29417055</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Petrucelli</surname> <given-names>M. F.</given-names></name>
<name><surname>Peronni</surname> <given-names>K.</given-names></name>
<name><surname>Sanches</surname> <given-names>P. R.</given-names></name>
<name><surname>Komoto</surname> <given-names>T. T.</given-names></name>
<name><surname>Matsuda</surname> <given-names>J. B.</given-names></name>
<name><surname>Silva</surname> <given-names>W. A. D.</given-names> <suffix>Jr</suffix></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>Dual RNA-Seq analysis of Trichophyton rubrum and HaCat keratinocyte co-culture highlights important genes for fungal-host interaction</article-title>. <source>Genes.</source> <volume>9</volume>, <fpage>362</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/genes9070362</pub-id>, PMID: <pub-id pub-id-type="pmid">30029541</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pham</surname> <given-names>C. D.</given-names></name>
<name><surname>Ahn</surname> <given-names>S.</given-names></name>
<name><surname>Turner</surname> <given-names>L. A.</given-names></name>
<name><surname>Wohrle</surname> <given-names>R.</given-names></name>
<name><surname>Lockhart</surname> <given-names>S. R.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>Development and validation of benomyl birdseed agar for the isolation of <italic>Cryptococcus</italic> neoformans and <italic>Cryptococcus</italic> gattii from environmental samples</article-title>. <source>Med. Mycol.</source> <volume>52</volume>, <fpage>417</fpage>&#x2013;<lpage>421</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/mmy/myt028</pub-id>, PMID: <pub-id pub-id-type="pmid">24782104</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Phillips</surname> <given-names>A. J.</given-names></name>
<name><surname>Crowe</surname> <given-names>J. D.</given-names></name>
<name><surname>Ramsdale</surname> <given-names>M.</given-names></name>
</person-group> (<year>2006</year>). 
<article-title>Ras pathway signaling accelerates programmed cell death in the pathogenic fungus Candida albicans</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>103</volume>, <fpage>726</fpage>&#x2013;<lpage>731</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0506405103</pub-id>, PMID: <pub-id pub-id-type="pmid">16407097</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Priebe</surname> <given-names>S.</given-names></name>
<name><surname>Kreisel</surname> <given-names>C.</given-names></name>
<name><surname>Horn</surname> <given-names>F.</given-names></name>
<name><surname>Guthke</surname> <given-names>R.</given-names></name>
<name><surname>Linde</surname> <given-names>J.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>FungiFun2: a comprehensive online resource for systematic analysis of gene lists from fungal species</article-title>. <source>Bioinformatics.</source> <volume>31</volume>, <fpage>445</fpage>&#x2013;<lpage>446</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btu627</pub-id>, PMID: <pub-id pub-id-type="pmid">25294921</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pruneda</surname> <given-names>J. N.</given-names></name>
<name><surname>Bastidas</surname> <given-names>R. J.</given-names></name>
<name><surname>Bertsoulaki</surname> <given-names>E.</given-names></name>
<name><surname>Swatek</surname> <given-names>K. N.</given-names></name>
<name><surname>Santhanam</surname> <given-names>B.</given-names></name>
<name><surname>Clague</surname> <given-names>M. J.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>A Chlamydia effector combining deubiquitination and acetylation activities induces Golgi fragmentation</article-title>. <source>Nat. Microbiol.</source> <volume>3</volume>, <fpage>1377</fpage>&#x2013;<lpage>1384</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-018-0271-y</pub-id>, PMID: <pub-id pub-id-type="pmid">30397340</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rawlings</surname> <given-names>J. S.</given-names></name>
<name><surname>Rosler</surname> <given-names>K. M.</given-names></name>
<name><surname>Harrison</surname> <given-names>D. A.</given-names></name>
</person-group> (<year>2004</year>). 
<article-title>The JAK/STAT signaling pathway</article-title>. <source>J. Cell science.</source> <volume>117</volume>, <fpage>1281</fpage>&#x2013;<lpage>1283</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.00963</pub-id>, PMID: <pub-id pub-id-type="pmid">15020666</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Regazzetti</surname> <given-names>C.</given-names></name>
<name><surname>De Donatis</surname> <given-names>G. M.</given-names></name>
<name><surname>Ghorbel</surname> <given-names>H. H.</given-names></name>
<name><surname>Cardot-Leccia</surname> <given-names>N.</given-names></name>
<name><surname>Ambrosetti</surname> <given-names>D.</given-names></name>
<name><surname>Bahadoran</surname> <given-names>P.</given-names></name>
<etal/>
</person-group>. (<year>2015</year>). 
<article-title>Endothelial cells promote pigmentation through endothelin receptor B activation</article-title>. <source>J. Invest. Dermatol.</source> <volume>135</volume>, <fpage>3096</fpage>&#x2013;<lpage>3104</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/jid.2015.332</pub-id>, PMID: <pub-id pub-id-type="pmid">26308584</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Riebisch</surname> <given-names>A. K.</given-names></name>
<name><surname>M&#xfc;hlen</surname> <given-names>S.</given-names></name>
<name><surname>Beer</surname> <given-names>Y. Y.</given-names></name>
<name><surname>Schmitz</surname> <given-names>I.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Autophagy&#x2014;a story of bacteria interfering with the host cell degradation machinery</article-title>. <source>Pathogens.</source> <volume>10</volume>, <fpage>110</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens10020110</pub-id>, PMID: <pub-id pub-id-type="pmid">33499114</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ries</surname> <given-names>L. N. A.</given-names></name>
<name><surname>Beattie</surname> <given-names>S.</given-names></name>
<name><surname>Cramer</surname> <given-names>R. A.</given-names></name>
<name><surname>Goldman</surname> <given-names>G. H.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Overview of carbon and nitrogen catabolite metabolism in the virulence of human pathogenic fungi</article-title>. <source>Mol. Microbiol.</source> <volume>107</volume>, <fpage>277</fpage>&#x2013;<lpage>297</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mmi.13887</pub-id>, PMID: <pub-id pub-id-type="pmid">29197127</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rohde</surname> <given-names>J.</given-names></name>
<name><surname>Emschermann</surname> <given-names>F.</given-names></name>
<name><surname>Knittler</surname> <given-names>M. R.</given-names></name>
<name><surname>Rziha</surname> <given-names>H.-J.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Orf virus interferes with MHC class I surface expression by targeting vesicular transport and Golgi</article-title>. <source>BMC veterinary Res.</source> <volume>8</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1746-6148-8-114</pub-id>, PMID: <pub-id pub-id-type="pmid">22809544</pub-id>
</mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Selezneva</surname> <given-names>A.</given-names></name>
<name><surname>Gibb</surname> <given-names>A. J.</given-names></name>
<name><surname>Willis</surname> <given-names>D.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>The Nuclear envelope as a regulator of immune cell function</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <elocation-id>840069</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.840069</pub-id>, PMID: <pub-id pub-id-type="pmid">35757775</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname> <given-names>J. A.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Regulation of cytokine production by the unfolded protein response; implications for infection and autoimmunity</article-title>. <source>Front. Immunol.</source> <volume>9</volume>, <elocation-id>422</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.00422</pub-id>, PMID: <pub-id pub-id-type="pmid">29556237</pub-id>
</mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Steen</surname> <given-names>B.</given-names></name>
<name><surname>Zuyderduyn</surname> <given-names>S.</given-names></name>
<name><surname>Toffaletti</surname> <given-names>D.</given-names></name>
<name><surname>Marra</surname> <given-names>M.</given-names></name>
<name><surname>Jones</surname> <given-names>S.</given-names></name>
<name><surname>Perfect</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2003</year>). 
<article-title><italic>Cryptococcus</italic> neoformans gene expression during experimental cryptococcal meningitis</article-title>. <source>Eukaryot Cell.</source> <volume>2</volume>, <fpage>1336</fpage>&#x2013;<lpage>1349</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/EC.2.6.1336-1349.2003</pub-id>, PMID: <pub-id pub-id-type="pmid">14665467</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tapia</surname> <given-names>C. V.</given-names></name>
<name><surname>Falconer</surname> <given-names>M.</given-names></name>
<name><surname>Tempio</surname> <given-names>F.</given-names></name>
<name><surname>Falc&#xf3;n</surname> <given-names>F.</given-names></name>
<name><surname>L&#xf3;pez</surname> <given-names>M.</given-names></name>
<name><surname>Fuentes</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2014</year>). 
<article-title>Melanocytes and melanin represent a first line of innate immunity against Candida albicans</article-title>. <source>Med. mycology.</source> <volume>52</volume>, <fpage>445</fpage>&#x2013;<lpage>454</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/mmy/myu026</pub-id>, PMID: <pub-id pub-id-type="pmid">24934806</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tavares</surname> <given-names>E. R.</given-names></name>
<name><surname>Gionco</surname> <given-names>B.</given-names></name>
<name><surname>Morguette</surname> <given-names>A. E. B.</given-names></name>
<name><surname>Andriani</surname> <given-names>G. M.</given-names></name>
<name><surname>Morey</surname> <given-names>A. T.</given-names></name>
<name><surname>do Carmo</surname> <given-names>A. O.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Phenotypic characteristics and transcriptome profile of <italic>Cryptococcus</italic> gattii biofilm</article-title>. <source>Sci. Rep.</source> <volume>9</volume>, <fpage>6438</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-42896-2</pub-id>, PMID: <pub-id pub-id-type="pmid">31015652</pub-id>
</mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tay</surname> <given-names>S. T.</given-names></name>
<name><surname>Lim</surname> <given-names>H. C.</given-names></name>
<name><surname>Tajuddin</surname> <given-names>T. H.</given-names></name>
<name><surname>Rohani</surname> <given-names>M. Y.</given-names></name>
<name><surname>Hamimah</surname> <given-names>H.</given-names></name>
<name><surname>Thong</surname> <given-names>K. L.</given-names></name>
</person-group> (<year>2006</year>). 
<article-title>Determination of molecular types and genetic heterogeneity of <italic>Cryptococcus</italic> neoformans and C. gattii in Malaysia</article-title>. <source>Med. Mycol.</source> <volume>44</volume>, <fpage>617</fpage>&#x2013;<lpage>622</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13693780600857330</pub-id>, PMID: <pub-id pub-id-type="pmid">17071555</pub-id>
</mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Taylor-Smith</surname> <given-names>L. M.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title><italic>Cryptococcus</italic>&#x2013;epithelial interactions</article-title>. <source>J. Fungi.</source> <volume>3</volume>, <fpage>53</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/jof3040053</pub-id>, PMID: <pub-id pub-id-type="pmid">29371569</pub-id>
</mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Voelz</surname> <given-names>K.</given-names></name>
<name><surname>May</surname> <given-names>R. C.</given-names></name>
</person-group> (<year>2010</year>). 
<article-title>Cryptococcal interactions with the host immune system</article-title>. <source>Eukaryot Cell.</source> <volume>9</volume>, <fpage>835</fpage>&#x2013;<lpage>846</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/EC.00039-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20382758</pub-id>
</mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xiao</surname> <given-names>L.</given-names></name>
<name><surname>Huang</surname> <given-names>H.</given-names></name>
<name><surname>Fan</surname> <given-names>S.</given-names></name>
<name><surname>Zheng</surname> <given-names>B.</given-names></name>
<name><surname>Wu</surname> <given-names>J.</given-names></name>
<name><surname>Zhang</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Ferroptosis: A mixed blessing for infectious diseases</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>, <elocation-id>992734</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2022.992734</pub-id>, PMID: <pub-id pub-id-type="pmid">36160441</pub-id>
</mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname> <given-names>Y.</given-names></name>
<name><surname>Eissa</surname> <given-names>N. T.</given-names></name>
</person-group> (<year>2010</year>). 
<article-title>Autophagy in innate and adaptive immunity</article-title>. <source>Proc. Am. Thorac. Society.</source> <volume>7</volume>, <fpage>22</fpage>&#x2013;<lpage>28</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1513/pats.200909-103JS</pub-id>, PMID: <pub-id pub-id-type="pmid">20160145</pub-id>
</mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname> <given-names>X.</given-names></name>
<name><surname>Lin</surname> <given-names>D.</given-names></name>
<name><surname>Tu</surname> <given-names>S.</given-names></name>
<name><surname>Gao</surname> <given-names>S.</given-names></name>
<name><surname>Shao</surname> <given-names>A.</given-names></name>
<name><surname>Sheng</surname> <given-names>J.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Is ferroptosis a future direction in exploring cryptococcal meningitis</article-title>? <source>Front. Immunol.</source> <volume>12</volume>, <elocation-id>598601</elocation-id>., PMID: <pub-id pub-id-type="pmid">33815361</pub-id>
</mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yamaguchi</surname> <given-names>Y.</given-names></name>
<name><surname>Hearing</surname> <given-names>V. J.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>Melanocytes and their diseases</article-title>. <source>Cold Spring Harbor Perspect. Med.</source> <volume>4</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/cshperspect.a017046</pub-id>, PMID: <pub-id pub-id-type="pmid">24789876</pub-id>
</mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname> <given-names>C.</given-names></name>
<name><surname>Huang</surname> <given-names>Y.</given-names></name>
<name><surname>Zhou</surname> <given-names>Y.</given-names></name>
<name><surname>Zang</surname> <given-names>X.</given-names></name>
<name><surname>Deng</surname> <given-names>H.</given-names></name>
<name><surname>Liu</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title><italic>Cryptococcus</italic> escapes host immunity: What do we know</article-title>? <source>Front. Cell. Infection Microbiol.</source> <volume>1570</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.1041036</pub-id>, PMID: <pub-id pub-id-type="pmid">36310879</pub-id>
</mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname> <given-names>C.-H.</given-names></name>
<name><surname>Chen</surname> <given-names>Y.</given-names></name>
<name><surname>Desjardins</surname> <given-names>C. A.</given-names></name>
<name><surname>Tenor</surname> <given-names>J. L.</given-names></name>
<name><surname>Toffaletti</surname> <given-names>D. L.</given-names></name>
<name><surname>Giamberardino</surname> <given-names>C.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>Landscape of gene expression variation of natural isolates of Cryptococcus neoformans in response to biologically relevant stresses</article-title>. <source>Microbial Genomics</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mgen.0.000319</pub-id>, PMID: <pub-id pub-id-type="pmid">31860441</pub-id>
</mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname> <given-names>C.-H.</given-names></name>
<name><surname>Sephton-Clark</surname> <given-names>P.</given-names></name>
<name><surname>Tenor</surname> <given-names>J. L.</given-names></name>
<name><surname>Toffaletti</surname> <given-names>D. L.</given-names></name>
<name><surname>Giamberardino</surname> <given-names>C.</given-names></name>
<name><surname>Haverkamp</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Gene expression of diverse <italic>Cryptococcus</italic> isolates during infection of the human central nervous system</article-title>. <source>Mbio.</source> <volume>12</volume>, <fpage>e02313</fpage>&#x2013;<lpage>e02321</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.02313-21</pub-id>, PMID: <pub-id pub-id-type="pmid">34724829</pub-id>
</mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname> <given-names>Y.</given-names></name>
<name><surname>Huang</surname> <given-names>Y.</given-names></name>
<name><surname>Yang</surname> <given-names>C.</given-names></name>
<name><surname>Zang</surname> <given-names>X.</given-names></name>
<name><surname>Deng</surname> <given-names>H.</given-names></name>
<name><surname>Liu</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>The pathways and the mechanisms by which <italic>Cryptococcus</italic> enters the brain</article-title>. <source>Mycology.</source> <volume>15</volume>, <fpage>345</fpage>&#x2013;<lpage>359</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21501203.2023.2295409</pub-id>, PMID: <pub-id pub-id-type="pmid">39247889</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/500953">Mohamed I. Husseiny Elsayed</ext-link>, City of Hope, United States</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/31546">Karen L. Wozniak</ext-link>, Oklahoma State University, United States</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2964374">Mohamed Hamed</ext-link>, Mansoura University, Egypt</p></fn>
</fn-group>
</back>
</article>